president’s message - scabb

1

President’s Message

.................................................................................................................www.scabb.org

Kirk Kitchen, MT(ASCP)SBB55th President

Happy 55th Annual Meeting of the South CentralAssociation of Blood Banks and welcome toBaton Rouge! The Annual Meeting promises ane n e rgetic program full of topics of great intere s t ,as well as fun activities. We offer up to 15 hours ofcontinuing education credits that cannot bebeat for the price. Also, the time spent with peers,friends, vendors and other associates cannot beparalleled. The event is varied and offers some-thing for everyone. You will not want to miss amoment from our opening Plenary with Stanley“Skip” Bertman to the Karen Williams MemorialL e c t u re with Dr. Bre c h e r, and so much value inbetween. We are fortunate to have the caliber offaculty at this year’s program. Now that you havethis program in your hands—check it out! There ’ splenty to do from industry workshops, award cer-emonies and lectureships, program tracks, golf-ing, running, social events, Exhibit Hall, food,music…the list never ends.

But before I gotta geaux I want to thank you forjoining us and participating in our program asl e a rners, presenters, sponsors, vendors and mem-bers. Without all of you, this could never happen.Enjoy the meeting!

Welcome to Baton Rouge!

Jambalaya, Crawfish Pie and FileGumbo – You Gotta Geaux

Unique Cajun cuisine is only one reason to Geaux to the SCABBAnnual Meeting in Baton Rouge April 18-21, 2013 at the Belle of BatonRouge Hotel and Casino. You gotta Geaux to take advantage of allof the other exciting and enriching activities that are planned. SkipBertman, legendary LSU baseball coach and former LSU AthleticD i re c t o r, will get things started as the Opening Plenary Speaker. Skip’sability to mold individuals to form cohesive and highly successfulteams is unique. He will share with us some of the techniques he usedto accomplish this!

The Exhibit Hall Grand Opening is sure to get things buzzing as kinfolkscome see the vendors by the dozen. Zydeco music and alligatorhunters and a spring thaw swollen Mississippi River full from levee tolevee will keep everyone on their toes. The glass covered Exhibit Hall isnot only beautiful but unique – you gotta Geaux to see it!

Educational opportunities will abound. One session brings all thre etracks together to discuss the challenges of reducing the risk of bacte-rially contaminated platelets. Outstanding speakers and programs will discuss the hottest topics in blood banking across all three tracks –Administrative, Technical-Scientific and Donor Recruitment andC o l l e c t i o n s .

But cher, we’ll pass a good time too yeah. The Annual Ed Moore Golf To u rnament is scheduled for Thursday, April 18, 2013 from 8 AM toNoon at the nearby LSU Golf Course. The planned Fun Run route putsus on top of the Mississippi River levee where runners will marvel as 1.5million cubic feet of water per second pushes south through BatonRouge to the Gulf of Mexico. Now don’t forget that the AnnualMeeting is being held at a casino. Gaming opportunities are only afew steps away and I hear that the slots are almost as hot as boiledcrawfish and that’s almost as good as cold raw oysters – and by theway, both will be in season during the meeting.

The Aw a rds Banquet, which will be held in the Old Govern o r ’ sMansion, will be the perfect venue as we recognize distinguishedAw a rd recipients, protégés and many others. The Mansion’s statelyp resence and rich history will definitely help to make the evening spe-cial and memorable. Be pre p a red for some fais-do-do (dancing).

This is the first time that Baton Rouge has hosted the SCABB AnnualMeeting and the Local Arrangements Committee Members are work-ing hard make it a “Geaux to” event. See you there ! !

EXECUTIVE COMMITTEEPresidentKirk Kitchen, MT(ASCP)SBBAmerican Red Cross1814 B West Abingdon DriveAlexandria, VA 22134Office: [email protected]

President-ElectJeannie Gardner, RNOklahoma Blood Institute1001 N. Lincoln Blvd.Oklahoma City, OK 73104Office: [email protected]

Vice PresidentTom ChoiUnited Blood Services1125 Terminal WayReno, NV 89502-2114Office: [email protected]

TreasurerChristie Loe-Malone, MT(ASCP)SBBCharter Medical, Ltd.259 Valencia CircleSt. Petersburg, FL 33716Office: [email protected]

SecretarySarah Jones, MT(ASCP)SBBSt. Luke’s Donor Center9720 Broadway, #1028Pearland, TX 77584Office: [email protected]

Immediate Past PresidentJose GarciaQualTex Laboratories6211 IH-10 WestSan Antonio, TX 78201Office: [email protected]

DISTRICT DIRECTORSDistrict I – (TX)Diane Lechuga, MT BB (ASCP)Corpus Christi Medical Center3315 South Alameda,PO BOX 8991Corpus Christi, TX 78411Office: [email protected]

James GiacolettiCarter BloodCare2205 Highway 121Bedford, TX 76021Office: [email protected]

District II(AZ, NM, CO, OK, NV)Dustin ConoverOklahoma Blood Institute1101 N. Lincoln BoulevardOklahoma City, OK 73104Office: [email protected]

District III (AR, LA, MS)David Gremillion,MT(ASCP)SBB MS HPOur Lady of the LakeRegional Medical Center5000 Hennessy Blvd.Baton Rouge, LA 70808Office: [email protected]

District-at-LargeLeeAnn Walker, MEd, MT(ASCP)SBBImmucor, Inc.3130 Gateway Dr.Norcross, GA 30071Office: [email protected]

Central OfficeKarla Darnall, Executive DirectorSouth Central Association of BloodBanks866-649-6550 Ph866-649-6590 Fxwww.scabb.orgTina Hargis, Education/RegistrarLiz Pearce, AccountingAshley Combs, Member Services

................................................................................................................. 2

SCABB Final Program

www.scabb.org

ContactFor more information about SouthCentral Association of Blood Banks,visit the website w w w . s c a b b . o r g o rcall 8 6 6 - 6 4 9 - 6 5 5 0 .

Contents

1 P resident’s We l c o m e

3 Industry Wo r k s h o p s

4 Distinguished Aw a rd Lecture r s

11-23 Detailed Program Schedule

25 P rotégé/Mentor Inform a t i o n

27-28 Aw a rd Wi n n e r s

29-36 Abstract Journ a l

39-41 Exhibitor Dire c t o r y

44-45 Schedule at a Glance

Mission StatementSouth Central Association of BloodBanks is a non-profit org a n i z a t i o nconsisting of nine states (TX, AZ, CO,NM, NV, OK, AR, LA, MS). It is ourmission to provide opportunities formembers to enhance their abilitiesto deliver quality blood services.

2012-2013 Board of Directors

2013 Industry Workshops

Informative & Diverse Content

SCABB Vendor Partners offer Industry Workshops during the Annual Meeting & AIMS. Full details can be found in the DetailedP rogram Schedule starting on page 11. Industry Workshops are off e red at no charge and are open to the public.

THURSDAY, APRIL 18, 20132:15 - 3:15 PMP r e s e n t a t i o n :QC Management - Practical Guide onthe use of Statistical Process Controls toMeet Latest Guidelines.Presented by:Sigma Blood Systems, LLCS p e a k e r ( s ) :Max Doleh and Patrick SaxtonSigma Blood Systems, LLC

3:30 - 4:30 PMP r e s e n t a t i o n :A p h e resis for ExellencePresented by:Fenwal, a Fresenius Kabi CompanyS p e a k e r ( s ) :Mary McCarthy, OneBlood & KathyMickles, Fenwal, a Fresenius KabiC o m p a n y

FRIDAY, APRIL 19, 20137:30 - 8:30 AMP r e s e n t a t i o n :TRALI: Research and Innovations on theRoad to Pre v e n t i o nPresented by:Terumo BCTS p e a k e r ( s ) :R i c h a rd J. Benjamin, MD PhD FRCPathAmerican Red Cross HollandL a b o r a t o r i e s

SATURDAY, APRIL 20, 20137:30 - 8:30 AMP r e s e n t a t i o n :Use of Te m p e r a t u re Indicators andTransport Cooler Va l i d a t i o nPresented by:William Laboratories, Inc.S p e a k e r ( s ) :Ed SharplessWilliam Laboratories, Inc.

Sunday, April 21, 201311:30am – 12:30 pmP r e s e n t a t i o n :Gold Standards in Immunohematology:Is It Time to Re-evaluate?Presented by:Novartis Vaccines & DiagnosticsS p e a k e r ( s ) :Nuria Nogues Galvez, PhD, Laboratorid’Immunohematologia Baric de Sang;Teisits and Jerry A. Holmberg, PhD,Novartis Vaccines and Diagnostics

Geaux Tweet!#bloodbankingonthebayou

Tweet About it#SCABBAM

The Ed Moore Golf Classic will be held at the LSU Golf Course in Baton Rouge, LA. The LSU golf course was establishedand built in 1961. Located 3 miles from downtown Baton Rouge on a 250-acre setting adjacent to LSU, this is an 18-hole links style course. Proceeds from the tournament will benefit the SCABB Foundation, which enhances the edu-cational goals of the Association through monetary support of current program offerings and member scholarships.

` `

3 .................................................................................................................www.scabb.org

4

2013 Award Lecturers

www.scabb.org

Administrative Award LecturerMary Beth Bassett, BS MT(ASCP)Executive Vice President, Chief Quality Off i c e rBlood Systems, Inc.Sunday, April 21st, 8:30 am

Since 1996, Mary Beth Bassett has servedas Executive Vice President Chief QualityO fficer at Blood Systems Inc. inScottsdale, Ariz. In this role, she is re s p o n s i-ble for the development and execution

of quality and regulatory programs for Blood Systems and theira ffiliates as well as Creative Testing Solutions. In addition, MaryBeth directs the perf o rmance improvement program (Lean SixSigma) for Blood Systems as well as directs the org a n i z a t i o n squality consulting service.

Ms. Bassett served as a member of the AABB (AdvancingTransfusion and Cellular Therapies Worldwide) Board of Dire c t o r sf rom 2008-2012. In 2011 she received the AABB’s Hemphill Jord a nLeadership Aw a rd in recognition of her dedication and out-standing leadership in the quality and compliance arena and forher willingness to freely share her expertise with others.Mary Beth will present, “Two Sides Of The Same Coin...TheBusiness Of Quality AND The Quality”, on April 21 at 8:30 am atthe SCABB Annual Meeting in Baton Rouge.

Technical/Scientific Award LecturerSusan T. Johnson, MSTM, MT(ASCP)SBBD i re c t o r, Clinical EducationBlood Center of Wi s c o n s i nSunday, April 21st, 9:15 am

In addition to Director of ClinicalEducation at Blood Center of Wi s c o n s i n ,Sue is also Director of the Specialist inBlood Banking (SBB) Program and theTransfusion Medicine program at

M a rquette University Graduate School. She is also AssociateD i rector of the Indian Immunohematology Initiative.

Sue has authored numerous publications in the field of Tr a n s -fusion Medicine and Immunohematology including co-author-ship of Judd’s Methods in Immunohematology. She is an established lecturer on a national and international basis on the topic of Immunohematology.

Sue has been an active member of AABB for over 25 years. Suec u r rently sits on the AABB Board of Directors, AABB Press EditorialB o a rd and is an Assessor for the Accreditation Program.

Sue will pre s e n t “Serologic Strengths - Limitations in AutomatedAge: The Success of Serology (S.O.S.)” will be presented by Sueat the Annual Meeting of SCABB on April 21 at 9:15 am in BatonR o u g e .

Karen Williams Memorial LecturerE n d owed by Novartis Diagnost i c s

Mark E. Brecher, MD (FCAP)Chief Medical Off i c e r, Senior Vice Pre s i d e n tLaboratory Corporation of AmericaSunday, April 21st, 10:15 am

D r. Brecher earned a Bachelor’s degre ein Chemistry from Emory University and aMedical degree from the University ofChicago. His postgraduate training

included a surgical internship and a residency in anatomic andclinical pathology at the University of Chicago followed by a fel-lowship in transfusion medicine/ blood banking at the MayoClinic. From 1988 until 1992 he was a staff physician with theMayo Clinic. He was on faculty at the University of North Caro l i n aat Chapel Hill from 1992-2009 where he was a full professor andvice-chair in the Department of Pathology and LaboratoryMedicine. In March of 2009, he became the chief medical off i-cer and a senior vice president for Laboratory Corporation ofA m e r i c a .

He is a past chair of the Department of Health and HumanServices Advisory Committee on Blood Safety and Availability, apast chief editor of the AABB Technical Manual and a pastP resident of the American Society for Apheresis.

D r. Brecher will present the closing lecturer for the 2013 AnnualMeeting in Baton Rouge on April 21st. His topic, “BacterialContamination of Blood Products” is relevant to all personsinvolved in the business of blood banking and transfusion medi-c i n e .

John Moulds Memorial LecturerE n d owed by Life S h a re Blood Ce n ters & Quotient Biodiagnost i c s

Marion E. Reid, PhD, DSc (Hon.)Head, Laboratory of ImmunochemistryNew York Blood CenterMonday, April 22nd, 9:30 am (AIMS re g i st ration re q u i re d )

D r. Reid trained as a medical technologistand later obtained a PhD and an hon-orary DSc. Her career of over 50 years, inEngland, California, and New York, hasfocused on various aspects of immunohe-

matology. She has co-authored over 400 peer- reviewed articlesand several books, and has received many award s .

D r. Reid will be hosting a book signing prior to and immediatelyafter her presentation, “Blood Group Systems: An Update”, onApril 22nd at the Advanced Immunohematology & MolecularSymposium in Baton Rouge, Louisiana.

.................................................................................................................

5

Meet the 56th President

.................................................................................................................www.scabb.org

Jeannie Gardner, RN - Oklahoma Blood Institute

I would like to take this opportunity to introduce and welcome Jeannie Gard n e r, our incoming SCABBP resident. Jeannie has been President-Elect for the past year and enters her new responsibility with a gre a tdeal of leadership experience. Jeannie is vice president of Donor Services at the Oklahoma Blood Instituteand has over 30 years of blood bank experience in both donor collections and therapeutic apheresis pro-grams. Jeannie also serves as the chair for the Heels for Hope foundation that focuses on raising muchneeded funds for ovarian cancer and works to educate and raise awareness of this disease. I have knownJeannie for many years and highly respect her integrity, drive and commitment to her family, community,

the health-care industry and to South Central Association of Blood Banks. I know you will give her the samesupport and level of confidence you have given me. Welcome, Jeannie!

American Red Cross Greater Ozarks RegionLittle Rock, AR

Baylor University Medical Center *Dallas, TX

Blood & Tissue Center of Central TexasAustin, TX

Blood Systems Laboratories *Tempe, AZ

Bonfils Blood Center *D e n v e r, CO

Carter BloodCare *B e d f o rd, TX

Coastal Bend Blood Center *Corpus Christi, TX

Coffee Memorial Blood Center *Amarillo, TX

Corpus Christi Medical CenterCorpus Christi, TX

Creative Testing Solutions *B e d f o rd, TX

Gulf Coast Regional Blood Center *Houston, TX

Medical Center of the RockiesLoveland, CO

Ochsner Medical Center - New Orleans *New Orleans, LA

Oklahoma Blood InstituteOklahoma City, OK

Our Lady of Lourdes RMCLafayette, LA

Our Lady of The Lake Reg Med Center *Baton Rouge, LA

Poudre Valley Hospital *Fort Collins, CO

Qualtex Laboratories *San Antonio, TX

Rio Grande Regional Hospital-Blood BankMcAllen, TX

South Texas Blood & Tissue Center *San Antonio, TX

St. Luke's Episcopal Hospital *Houston, TX

Texas Children's Hospital *Houston, TX

Texoma Regional Blood CenterS h e rman, TX

The Blood Center *New Orleans, LA

United Blood Services – Arizona *Scottsdale, AZ

United Blood Services - Gulf South RegionLafayette, LA

UT M.D. Anderson Cancer CenterHouston, TX

Associate Corporate Members

Act Fast Delivery *G a rden Ridge, TX

Charter Medical, Ltd.Winston Salem, NC

Group Services for America’s BloodCenters (GSABC)Bloomington, MN

Helmer ScientificNoblesville, IN

Interstate All BatteryDallas, TX

National Bus Sales & Leasing *Marietta, GA

Stellaray, IncorporatedAustin, TX

* = Sustaining Member

2013 Institutional Members

6

Blood Banking on the Bayou!

www.scabb.org

Mixing it up in Baton Rouge!Whether you are new to the Association, a first time attendee

or simply want to learn more so that you can become

m o re involved, you’ll want to geaux to this year’s Membership

& Protégé Mixer! In the courtyard of the Belle of Baton

Rouge, beginning at 3:30 pm on Thursday,

April 18th, you’ll have the opportunity to meet

with SCABB leadership, investigate committees,

and connect with others just like you!

(invitation only)

Sponsored by

Enjoy the scenic route on this 5K journey along the levee of Ole Man

R i v e r. Staged from the Belle of Baton Rouge Mississippi River walkway

on April 20th at 6:30 am, the waterf ront trail is sure to leave runners

and walkers alike energized, more focused, and incredibly

ready to enjoy all of the Annual Meeting activities. All

participants will receive a t-shirt and snacks. P re - registration

is encouraged via www.scabb.org > annual meeting.

A special thank you to Our Lady of the Lake Regional Medical Center for sponsoring this year’s Fun Run t-shirts.

2013 Fun Run/Walk

.................................................................................................................

7

2012-2013 Committees

.................................................................................................................www.scabb.org

Administrative ProgramsRick Chatelain, ChairRobert de JonghChristi Bro o k sGalen KlineJanice HoneycuttLinda BossardLisa Fults

AIMS Katrina Billingsley, ChairVi rginia Reyes, Co-ChairL a u ro GuerraSuzanne DavissonM a rg a ret KellerSandy Wo r t m a nG e o rge ArterberryGloria Mathur

Awards Sarah Jones, ChairLaura Korte, Co-ChairTom ChoiLinda MazikDan HoughtonClint HuffMelonye RodgersLara ThedfordConnie BornMatthew PoncinJennifer PackardDiane LeChugaSarah HartmanM e redith Reyes

BylawsJose Garc i a

Donor Recruitment ProgramFrances Carson, ChairSusan Crews, Co-ChairStephanie BabinRon ChavezToni DouglasJoyce KleistLinda MazikTammy WhiteleyJessica Millet

Danny LottJennifer GonzalesClint HuffChad DouglasTroy DahmanChris Wa rdMichelle Fore m a nBrandi Wr i g h t

EducationGloria Mathur, ChairMary Berg, Co-ChairChantel HarrisonO'Dina HurlburtKirk KitchenRebecca BullockJeanie ChuiRoberta Murf i n

ExhibitsJames Boone, ChairBelinda Flores, Co-ChairKerry RodriguezP romise BryantLori Lesniewski

FinanceChristie Loe, ChairChris Coff i nPaula KelleyRick ChatelainDiane Lechuga

Fundraising Sub-committeeJames BooneJulie Ontivero sJose Garcia, LiasionTom Choi, Liasion

History & ArchivesJanet Vincent, ChairJames Giacoletti, Co-ChairHannah AcevedoMarilyn MouldsKathie CarlsonBill Te a g u eChris Coff i n

Information TechnologyShonnah Schlabach, ChairDarrin GannawayLinda ApplegateEllen We a v e rMatthew Poncin

Local ArrangementsDavid Gremillion, ChairLeaAnn Te a g u eJames Te a g u eStephanie BabinAmanda LandersJason ConnerJessica Millet

MembershipTerri Poulin, ChairJose Garc i aMandi Born h o e f tI rma Vi l l a r re a lTom ChoiDavid Gre m i l l i o nDiane LeChugaJames GiacolettiLeeAnn Wa l k e rDustin Conover

NominatingChris Coffin, ChairHannah AcevedoLeeAnn Wa l k e rRon Hein

PlanningJeannie Gard n e r

Protégé/MentorshipRoberta Murfin, Co-ChairDustin Conover, Co-ChairKirk KitchenChris Coff i nCheri JenningsSarah JonesJoe RidleyPaula KelleyGerald HamanTom Choi

PublicationsSusie Hart, ChairC l a re Wong, Co-ChairHannah AcevedoAutumne PriceShirley Shaff e r

Technical/Scientific ProgramsDiane Lechuga, ChairLara Thedford, Co-ChairLisa FultsBarbara BryantSusan EppersonGloria MathurRebecca BullockNicole PetersI rma Vi l l a r re a lJoann MouldsK a ren WhittenAnn Catro nJennifer PackardRyan NoblesAlice Chen

8

Opening Plenary

www.scabb.org

Geaux to Opening Plenary on Thursday, April 18th, 4:45 pmLouisiana Legend and one of the greatest college baseball coaches of all time, Stanley “Skip” Bertman,

made the seamless transition into the athletics director’s chair with the same enthusiasm, vision anddemand for excellence that were trademarks of his stellar coaching care e r. After his tenure ended onJune 30, 2008, he remained at LSU as athletics director emeritus through 2010, working as a vital fund-raiser for the university. In six years as LSU’s director of athletics, Bertman added to his impressive list ofon-the-field achievements. Under his direction, LSU enjoyed arguably the greatest athletics seasonsin the history of the institution. The 2006-07 season saw 12 LSU teams finish among the nation’s top 25,

including a No. 3 final ranking for the football team and a fourth consecutive Final Four appearanceby the women’s basketball squad. The LSU men’s and women’s track and field teams each finished

No. 2 in the nation. In 2005-06, LSU joined North Carolina (1997-98) as the only schools to have their foot-ball, men’s basketball and women’s basketball teams all finish in the nation’s Top 5. Bertman’s unyielding

d e s i re to succeed drove him to the pinnacle of his profession, and his astute knowledge of the game -- obtainedf rom over 40 years of coaching -- combined with his steadfast determination and irre p ressible enthusiasm trans-f o rmed LSU Athletics into the nation's premier program. Bertman has been inducted into the College BaseballHall of Fame, the Louisiana Sports Hall of Fame and the American Baseball Coaches Association Hall of Fame.Bertman has established himself as a much sought after motivational speaker whose ideas about teamworkand cooperation are concepts that energize all who hear him speak.

A special thanks to the SCABB Foundation for their financial support of this year’s opening plenary speaker.

.................................................................................................................

9

SCABB Annual Business Meeting

.................................................................................................................www.scabb.org

EXECUTIVE COMMITTEE

P r e s i d e n tJeannie Gard n e r, OklahomaBlood Institute, OklahomaCity, OK

President ElectTom Choi, Blood Systems,Scottsdale, AZ

Vice PresidentSarah Jones, St. Luke'sEpiscopal Hospital, Houston, TX

S e c r e t a r yDiane Lechuga, HCA,Corpus Christi MedicalC e n t e r, Corpus Christi, TX

T r e a s u r e rChristie Loe-Malone, Charter Medical, Ltd., St. Petersburg, FL

Immediate Past-PresidentKirk Kitchen, American RedC ross, Washington, DC

DISTRICT DIRECTORS

District I - TXJulie Ontiveros, Coff e eMemorial Blood Center,Amarillo, TX

District II (AZ, NM, CO, OK,N V )Dustin Conover, OklahomaBlood Institute, OklahomaCity, OK

District Directors with anotheryear in their 2 year term

District I - TXJames Giacoletti, CarterB l o o d C a re, Bedford, TX

District III (AR, LA, MS)David Gremillion, Our Ladyof the Lakes RegionalMedical Center, BatonRouge, LA

District at LargeLeeAnn Wa l k e r, Immucor,N o rc ross, GA

2013 Slate of Nominees

The Annual Business Meeting is open to allmembers of SCABB.

The agenda includes:

• Election of Off i c e r s

• Association Financial Report

• SCABB Foundation Report

• Bylaw Changes (if any)

• Recognition of Member Milestone Achievements

• Announcement of 2014 Annual Meeting Site

The Bylaws Committee has presented to the SCABB Board ofD i rectors that there are no Bylaw changes to be considered atthis time.

Institutional members should make every effort to have theirVoting Delegate present at the Annual Business meeting of theA s s o c i a t i o n .

11

Detailed Program Schedule

.................................................................................................................www.scabb.org

CONTINUING EDUCATION CREDITS (CEU’s)

The South Central Association of Blood Banks AnnualMeeting has been approved as a provider of continuingeducation programs in the clinical laboratory sciencest h rough the ASCLS P.A.C.E. program. The approved coursesqualify for 1.0 - 1.5 contact hours each, depending on thelength of the presentation. Participants attending one ses-sion in each time block will earn a maximum of 15 contacthours. All approved sessions will be indicated with byP.A.C.E. course number beginning with 151.

Attendees from the state of Florida can download cre d i t sfor this year’s sessions via CE Broker www.cebro k e r. c o m .This year’s program will also offer CME credits.

A c c reditation: The Ochsner Clinic Foundation is accre d i t e dby the Accreditation Council for Continuing MedicalEducation to provide continuing medical education forphysicians. Designation: The Ochsner Clinic Foundation des-ignates this educational activity for a maximum of 16 AMAPRA Category 1 Credits™. Physicians should only claimc redit commensurate with the extent of their participation inthe activity.

R U Scanned? Attendance at each breakout will be cap-tured via badge scan. Make sure that you are scanned asyou enter the room to insure credit for your attendance.

THURSDAY, 4/18/20132:15 - 3:15 PMBaton Rouge We s tIndustry Workshop

P r e s e n t a t i o n : QC Management - Practical Guide on the use of Statistical Process Controls to Meet Latest Guidelines.

Presented by: Sigma Blood Systems, LLC.

S p e a k e r ( s ) : Max Doleh and Patrick SaxtonSigma Blood Systems, LLC.

D e s c r i p t i o n : The FDA guidance for Pre-Storage LeukocyteReduction of Whole Blood and Blood Components Intended forTransfusion and Collection of Platelets by Automated Methods havec reated a dilemma for the blood banking community. Under 21CFR 211.160(b), laboratory controls must include the establishmentof scientifically sound and appropriate specifications, standard s ,sampling plans and testing pro c e d u res. A major question is how tocomply with these guidance documents. This workshop will discusspractical steps for blood centers to use SPC (statistical process con-t rols) to comply with FDA guidelines re g a rdless of their size.

3:30 - 4:30 PMBaton Rouge We s tIndustry Workshop

P r e s e n t a t i o n : A p h e resis for Exellence

Presented by: Fenwal, a Fresenius Kabi Company

S p e a k e r ( s ) : Mary McCarthy, OneBlood & Kathy Mickles,Fenwal, a Fresenius Kabi Company

D e s c r i p t i o n: This session will introduce Fenwal Customer Solutions, aconsultative service. We will review the proven tools and re s o u rc e so ff e red. OneBlood will showcase the highlights of how they havei m p roved the apheresis efficiency through the support of FenwalCustomer Solutions.

4:45 - 6:00 PMIberville A & B & C

M o d e r a t o r : Kirk Kitchen, MT (ASCP) SBB

Opening Plenary

S p e a k e r : Stanley "Skip" BertmanF o rmer Coach of LSU Baseball, Former LSU Atheletic Dire c t o rR e t i re d

P r e s e n t a t i o n : Hold the Rope

D e s c r i p t i o n : This talk includes why all people are special, and canaccomplish just about anything if they negotiate four hurdles. Firstthey must believe that they can, the single most common denomi-nator among all successful people is that they believe that theycan succeed. They have no mental barriers. Secondly, successfulpeople must motivate themselves and others. Motivation is re a l ,while it can’t be seen or touched, you know when it’s present ornot. Leadership, excellence, management and fear of failure arealso talked about. People are asked to see failure as somethingthat is temporary, a natural part of the laws of life. We must learn to“fail forward.” You will hear about the “national pastime,” not base-ball or football, but “transfer of blame” and why giving up re s p o n s i-bility means one has given up the ability to respond. Most impor-

Program Track KeyA d m i n i s t r a t i v e

Te c h n i c a l / S c i e n t i f i c

Donor Recruitment/Collections

AT/S

DRC

A T/S DRC

12


www.scabb.org.................................................................................................................

tantly you will hear about teamwork. It is impossible to overate theimportance of teamwork. The rhythms of teamwork are familiar toCoach Bertman. Team dynamics and bringing a group together sothat the whole is greater than the sum total of any of its parts hasbeen part of Coach Bertman’s legacy as a baseball coach andlater as athletics dire c t o r. Teamwork is the essence of life in sports,family, business, almost all professions and even re c re a t i o n .D e l i v e red with humor and intensity sometimes using examples fro mthe world of athletics, Coach Bertman will touch your heart andtickle your funny bone. You will be inspired as you learn to “Hold onto the Rope.”

O b j e c t i v e s : 1. E x p l o re the limitless abilities of people.2. Discuss how and why teamwork works.3. Challenge individuals to take re s p o n s i b i l i t y .

1 5 1 - 1 0 3 - 1 3PACE/CME/CEU Credits: 1 . 0

The Association acknowledges the SCABB Foundation for theirg e n e rous support of today’s opening plenary speaker.

FRIDAY, 4/19/20137:30 - 8:30 AMBaton Rouge We s tIndustry Workshop

P r e s e n t a t i o n : TRALI: Research and Innovations on the Roadto Pre v e n t i o n

Presented by: Terumo BCT

S p e a k e r : R i c h a rd J. Benjamin, MD PhD FRCPathAmerican Red Cross Holland Laboratories

D e s c r i p t i o n : Have TRALI mitigation strategies had a positive impacton the incidence of this adverse transfusion reaction? Join us in asession exploring what has been done and what can be done tomitigate TRALI. This session will include a presentation followed byg roup discussion.

8:45 - 10:00 AMIberville A & B

M o d e r a t o r : Jennifer Packard, MT (ASCP) SBB

"Baby Talk" - Neonatal Transfusion Concerns and Complications

S p e a k e r : Ghislain Noumsi, MD SBB (ASCP)Molecular ImmunohematologistL i f e S h a re Blood Centers

P r e s e n t a t i o n : P redicting Hemolytic Disease of the Fetus andN e w b o rn Using Monocyte Monolayer Assay ( M M A )

D e s c r i p t i o n : Using actual case studies, this presentation will describehow the monocyte monolayer assay can be used to predict HDNand provide blood.

O b j e c t i v e s : 1 . Describe HDFN and the MMA.2. D i ff e rentiate between HFDN due to Rh vs.

Kell antibodies.3. Demonstrate how MMA can be used to

select blood for a neonatal exchange transfusion when multiple antibodies are p re s e n t .

S p e a k e r : Daniel K. Noland, MD FCAPMedical Dire c t o r- Transfusion and Tissue Service, Assistant Pro f e s s o rC h i l d ren's Medical Center Dallas, UTSW

P r e s e n t a t i o n : Neonatal Thrombocytopenia: A Case Study

D e s c r i p t i o n : Use a recent case to discuss the diff e rential diagnosis(including lab testing) and treatment (including blood pro d u c tusage) of neonatal thombocytopenia.

O b j e c t i v e s : 1. Describe common causes of neonatal t h ro m b o c y t o p e n i a .

2. Define the roles of the clinician, lab and blood bank in treating neonatal t h ro m b o c y t o p e n i a .

3. Discuss the current literature re g a rding blood product usage in neonatalt h ro m b o c y t o p e n i a .


8:45 - 10:00 AMBaton Rouge We s t

M o d e r a t o r : Brandi Wr i g h t

Generational Management

S p e a k e r : Kathy To k e r u dP a r t n e rHuman Dynamics Inc

P r e s e n t a t i o n : Bridging the Generational Divide

D e s c r i p t i o n : Leaders and individual contributors will learn how torecognize, understand and adapt to the unique needs of the FourGenerations. They will walk away with some fundamental knowl-edge to bridge the generational divides that exist within their org a n-i z a t i o n s .

O b j e c t i v e s: 1. Recognize the 4 generations.2. Understand the diverse motivators of each

g e n e r a t i o n .3. Adapt approach to communicating and

leading based in part on generational p re f e re n c e s .


T/S

DRC


FRIDAY, 4/19/20138:45 - 10:00 AMBaton Rouge East

M o d e r a t o r: Lisa Fults, MT (ASCP)

Statewide Collaborations: ACTS & OneBlood

S p e a k e r : Bobby Grigsby, CPA MBAExecutive Vice President Strategic AlliancesCarter BloodCare

P r e s e n t a t i o n : Seizing Opportunities Through Strategic A l l i a n c e s

D e s c r i p t i o n : The speaker will address the need for forming strategicalliances and for mergers in a rapidly changing blood banking envi-ronment. Alliances, mergers and acquisitions will be discussed asmethods to seize opportunities as blood centers adapt to change.Some actual results in the speaker's experiences will be pre s e n t e d .

O b j e c t i v e s : 1. Describe the Alliance for Community Transfusion Services (ACTS).

2. Describe the advantages of alliances.3. Review successes with mergers and

a l l i a n c e s .

S p e a k e r : G e o rge "Bud" SchollExecutive Vice President / Chief Integration O fficer: OneBlood, Inc.

P r e s e n t a t i o n : M e rgers and Consolidations - Myth versus R e a l i t y

D e s c r i p t i o n : OneBlood was formed roughly one year ago as aresult of the merger of three large Florida regional blood centers.This presentation, from one of the principal architects of the merg e r,will describe the process with which the merger came about, theexpectations coming into the merg e r, the infrastructure that wasbuilt to meet those expectations and the challenges that havebeen faced during the integration pro c e s s .

O b j e c t i v e s : 1. P rovide a framework for executing a m e rg e r.

2. Set expectations for realistic benefits.3. Convey various challenges faced and

o v e rcome during the integration pro c e s s .1 5 1 - 1 0 6 - 1 3PACE/CME/CEU Credits: 1 . 0

10:00 - 10:15 AM – BREAK: Sponsored by Abbott Laboratories


M o d e r a t o r : Joann Moulds, PhD, MT (ASCP) SBB

Are You Smarter Than A MedTech Student?

S p e a k e r s : Joann Moulds, PhD MT (ASCP) SBBD i re c t o r, Scientific Support ServicesL i f e S h a re Blood Centers

Janet Vincent, MS SBB (ASCP)Education Coord i n a t o rUniversity of Texas Medical Branch

P r e s e n t a t i o n : A re You Smarter Than a Med Tech Student?

D e s c r i p t i o n : Using (confidential) audience participation devices,you will pit yourself against medical technology students to test yourknowledge of donors, blood groups, HDFN, antibody identification,and other serological techniques. The overall audience re s p o n s ewill be compared to the students' answers. Then you will find out ifyou really are smarter than a MT student.

O b j e c t i v e s : 1. Choose the correct blood type in a case of multiple antibodies.

2. Choose the correct blood for a neonatal t r a n s f u s i o n .

3. Get a higher exam score than the combined student score .


10:15 - 11:45 AMBaton Rouge We s t

M o d e r a t o r : Linda Mazik

QA Boot Camp

S p e a k e r : Brandi Wr i g h tManager of Mobile CollectionsCarter BloodCare

P r e s e n t a t i o n : Compliance Bootcamp for Collection Staff

D e s c r i p t i o n : Does your team make errors? Is compliance hard toexplain to your teams? Come see how we made our staff under-stand and buy-in.

O b j e c t i v e s : 1. R e i n f o rce compliance.2. Give a sample for how to get employee

b u y - i n .3. Show how it has affected the department

K P I .1 5 1 - 1 0 8 - 1 3PACE/CME/CEU Credits: 1 . 5

10:15 - 11:45 AMBaton Rouge East

M o d e r a t o r : Christi Brooks, MA MT, (ASCP), CQA(ASQ)

LEAN +

S p e a k e r : Galen Kline, CLSSBBD i re c t o r, Quality Audits and AnalysisBlood Systems

P r e s e n t a t i o n : LEAN +/- Functional LEAN

A

T/S

DRC

A

14www.scabb.org.................................................................................................................


FRIDAY, 4/19/201310:15 - 11:45 AM

D e s c r i p t i o n : The presentation will go in depth into Functional Lean.Functional Lean is a useful process to follow for administrative func-tions of any facility to assure the core functions determined to bevalue-added by the customer are supported affectively and nonvalue-added (waste) processes are eliminated or re d u c e d .

O b j e c t i v e s : 1. Describe Functional Lean and it's application at a Blood Center or Hospital.

2. Walk through the Functional Lean p ro c e s s o r s .

3. Discuss real life scenarios where it's been used.

S p e a k e r : Patrick Maul, MT (ASCP) MBA, Lean Six Sigma Black BeltPrincipal ConsultantBD Diagnostics - Healthcare Consulting

P r e s e n t a t i o n : LEAN Plus - What's Next?

D e s c r i p t i o n : The presentation is geared to the audience that knowswhat Lean is but is not quite sure what the next steps are to trulyimplement it into their workplace. The presentation will brieflydescribe the structure and environment necessary for success.Examples of success will be pre s e n t e d .

O b j e c t i v e s : 1. I n t roduce the concepts of creating a sustainable Lean enviro n m e n t .

2. Describe the types of projects that can be accomplished.

3. Discuss the structure re q u i red for success.1 5 1 - 1 0 9 - 1 3PACE/CME/CEU Credits: 1 . 5

11:45 - 1:00 PM – Lunch/Exhibit Hall OpeningCapital Atrium

1:00 - 2:30 PMIberville A & B

Moderator: Lara Thedford, BS, MT (ASCP) SBB

Radical Blood Banking

S p e a k e r : Christopher A. VanFosson, RN, MSN/MHA, M M A SM a j o r, Army NurseUnited States Arm y

P r e s e n t a t i o n : Use of Blood Products at a US Army Forward S u rgical Team in Afghanistan, Feb 2010-Feb 2011

D e s c r i p t i o n : MAJ VanFosson briefly introduces the Army forward sur-gical team before describing blood component therapy in such aspecialized medical team. VanFosson will explain the protocols and

guidelines for blood component therapy in Afghanistan, elaborateon challenges and limitations of such therapy in an austere enviro n-ment, and discuss whole blood transfusion in combat.

O b j e c t i v e s : 1. Describe the austere environment in which blood products are used to save lives.

2. Identify the challenges of blood component therapy in a combat zone.

3. Describe the importance of whole blood transfusion in the resuscitation of combat wounded patients.

S p e a k e r : Eugenia C. Bryan, MDAssociate Professor of PathologyUniversity of Texas Health Science Center-San AntonioUniversity Hospital San Antonio

P r e s e n t a t i o n : MTP at a Non-Military Hospital Blood Bank

D e s c r i p t i o n : This presentation will address the design and use of aspecific protocol in the provision of blood components to patientswith uncontrolled hemorrhage in a civilian hospital with a designa-tion of a Level I Trauma Center. The issues associated with maintain-ing hemostasis in rapidly bleeding patients.

O b j e c t i v e s : 1. Define massive transfusion and discuss the type of patients likely to re q u i re massive t r a n s f u s i o n .

2. Discuss the basis for the use of a Massive Tranfusion Pro t o c o l .

3. Describe the design and implementation of a Massive Transfusion Pro t o c o l .


1:00 - 2:30 PMBaton Rouge We s t

Moderator: Clint Huff

Donor Motivation

S p e a k e r : Todd Abner, BAVice President of Donor RecruitmentOklahoma Blood Institute

P r e s e n t a t i o n : Giving Blood: The Development of an Altruistic Identity

D e s c r i p t i o n : Everything old is new again. This session reviews the1991 work of Dr. Jane Piliavin and Peter Callero ”Giving Blood: theDevelopment of an Altruistic Identity.” Participants will learn initialmotivators in the development of an altruistic personality, size upmotivators quickly and re i n f o rce those donor motivators to re c re a t ea meaningful donor experience. Done right, re i n f o rced behaviors,coupled with a re w a rding donors experience yields a committed,life-long donor.

T/S

DRC

15 .................................................................................................................www.scabb.org

17


.................................................................................................................www.scabb.org

FRIDAY, 4/19/20131:00 - 2:30 PM

O b j e c t i v e s : 1. Describe behaviors/experience that lead to altruistic identities.

2. L e a rn how to quickly identify motivators in blood donors.

3. L e a rn how to foster a donor experience that supports development of an altruistic i d e n t i t y .


1:00 - 2:30 PMBaton Rouge East

M o d e r a t o r : Galen Kline, CLSSBB

Adult Learning

S p e a k e r : Christi Brooks, MA MT (ASCP) CQA (ASQ)D i rector of Blood Products/Clinical SpecialistIndependent Medical Associates

P r e s e n t a t i o n : Using Adult Learning Methods to Design Training Pro g r a m s

D e s c r i p t i o n : Training is a method of enhancing human perf o rm-ance. Whenever a person's ability to perf o rm a job is limited bylack of knowledge or skill, it makes sense to bridge the gap by pro-viding the re q u i red instruction. This session will uncover the nature ofhow adults learn and provide methods that go beyond lecturing top rovide lasting learn i n g .

O b j e c t i v e s : 1. Describe the nature of adult learn i n g .2. Select appropriate methods for helping adults learn in various situations.3. Implement new insights to blood bank related instructional design eff o r t s .


2:30 - 2:45 PM – BREAK: Sponsored by Abbott Laboratories


M o d e r a t o r : Garrick “Rick” Chatelain, MT (ASCP)

Secondary Bacterial Screening of Platelet Components

S p e a k e r : R i c h a rd Benjamin, MD PhDChief Medical Off i c e rAmerican Red Cro s s

P r e s e n t a t i o n : Bacterial Contamination of Platelets: Search for Solutions

D e s c r i p t i o n : Bacterial contamination of platelets remains the larg e s tinfectious risk of transfusion despite the implementation of ro u t i n ec u l t u re. Recent work highlights the residual risk to patients and off e r snew solutions through point of issue retesting. However, this comesat a price. This presentation will set the stage for a discussion of themerits and need for these new technologies.

O b j e c t i v e s : 1. Describe the results of routine bacterial c u l t u re testing in the US.

2. Estimate the residual risk of platelet c o n t a m i n a t i o n .

3. Outline approaches to minimizing risk to p a t i e n t s .

S p e a k e r : Louis M. Katz, MDExecutive VP/Chief Medical Off i c e rAmerica's Blood Centers

P r e s e n t a t i o n : Point of Issue Platelet Bacterial Testing: R e s o u rce Considerations

D e s c r i p t i o n : Will present a cost model used to assess the re l a t i o n-ship of re s o u rces for point of issue testing of platelets for bacterialcontamination to the re s o u rces used for other blood safety inter-v e n t i o n s .

O b j e c t i v e s : 1. Understand the operational characteristics of point of issue testing.

2. Understand the costs of the tests and bacterial sepsis from platelets.

3. Place these costs in the perspective of other blood safety measure s .

S p e a k e r : Patricia L. Williams, BS, MT (ASCP) SBBTransfusion Service ManagerBaylor University Medical Center

P r e s e n t a t i o n : Random Donor Platelet Testing for Bacterial Contamination: The Transfusion Service E x p e r i e n c e

D e s c r i p t i o n : AABB standard 5.1.5.1.1 re q u i res blood banks andtransfusion services to utilize FDA-approved detection methods forpossible bacterial contamination in platelet components.P resentation relates the experience of a large transfusion servicewith random donor platelets. Discussion includes description of thetest methodology and associated testing protocol. Challenges andsuccesses are pre s e n t e d .

O b j e c t i v e s : 1. Identify an example of transfusion service p rotocol for testing timing/fre q u e n c y .

2. Outline steps for resolution of a positive test.3. State challenges to testing.


4:15 - 6:00 PMExhibit Hall - Capital AtriumWine & Cheese Reception

A

A T/S DRC

18


www.scabb.org.................................................................................................................

FRIDAY, 4/19/20134:30 - 5:30 PMBaton Rouge East

M o d e r a t o r s : Arthur Bracey, MD and Chantal Harrison, MD

MD Roundtable

D e s c r i p t i o n : Join us for an open forum to discuss “up and coming”topics relevant to YOU!

O b j e c t i v e s : 1. Discuss and learn about current topics being dealt with at various locations.


SATURDAY, 4/20/20136:30 AM – SCABB Fun RunL o b b y

7:30 - 8:30 AMBaton Rouge We s tIndustry Workshop

P r e s e n t a t i o n : Use of Te m p e r a t u re Indicators and Transport Cooler Va l i d a t i o n

Presented by: William Laboratories, Inc.

S p e a k e r : Ed SharplessWilliam Laboratories, Inc.

D e s c r i p t i o n : Discussion of the challenge "What is happening to myblood when it leaves my blood bank?" and how temperature moni-toring is a great tattletale device. Take the pain out of transportcooler validations.

8:45 - 10:00 AMIberville A & B & C

M o d e r a t o r : Ryan Nobles, MLS (ASCP) c m SBB c m

Oral Abstracts Presentation

S p e a k e r : Michael Scabet, MT (ASCP) SBB

P r e s e n t a t i o n : P recision of Antibody Titration in Gel versus Tu b e

SCABB Sol Haberman Award Winner

S p e a k e r : Joann Moulds, PhD, MT (ASCP) SBB

P r e s e n t a t i o n : Is Molecular Typing More Accurate than S e rology for Blood Group Determination in a Donor Population?

S p e a k e r : Barbara Bryant, MD, MT (ASCP) SBB

P r e s e n t a t i o n : Evaluation of Platelet Progeny Production During Blood Bank Storage Conditions

S p e a k e r : Elizabeth Hill, MT (ASCP) SBB

P r e s e n t a t i o n : Comparison of Antibody Titers in Donor Specimens and Associated AS-1 Leukocyte-Reduced Donor Units

S p e a k e r : Yasmine King, MT (ASCP) SBB, MPH

P r e s e n t a t i o n : Rapid Thaw Plasma: As Good As the Regular S t u ff But Faster


10:00 - 10:15 AM – BREAK: Sponsored by Abbott Laboratories


M o d e r a t o r : Gloria Mathur, BScCHEM, MT (ASCP) SBB

"Cool Cases"

S p e a k e r : Alice J. Chen, MD PhDMedical Dire c t o r, Molecular Pathology Section; Associate Medical Dire c t o r, Blood Donor Pro g r a mSt. Luke's Episcopal Hospital

P r e s e n t a t i o n : Who's to Blame?: Hemolysis with Both a Wa rm and Cold Autoantibody

D e s c r i p t i o n : Case discussion of autoimmune hemolytic anemia withboth a warm and cold autoantibody, incorporating perspectivesf rom the clinician, the blood bank, and the re f e rence lab.

O b j e c t i v e s : 1. Describe serologic findings of warm and cold autoantibodies.

2. Understand a basic approach to hemolytic anemia from a clinical perspective.

3. Describe interactions between the clinician,the blood bank, and the re f e rence lab in cases of hemolytic anemia.

S p e a k e r : Te resa Bruce, MT (ASCP)IRL Te c h n o l o g i s tL i f e S h a re Blood Centers

P r e s e n t a t i o n : Wa rm AIHA: What Happens When You Peek Into the Genes

D e s c r i p t i o n : This session will feature cases from around the re g i o nand describe how each facility dealt with them.

O b j e c t i v e s : 1. Describe the typical seroloc findings in WA I H A .

2. List methods to diff e rentiate auto vs. allo a n t i b o d y .

3. Describe the role of genotyping in cases of positive DATs .


T/S

A T/S DRC

A T/S DRC

20


www.scabb.org.................................................................................................................

SATURDAY, 4/20/201310:15 - 11:45 AMBaton Rouge We s t

M o d e r a t o r : Susan Cre w s

Collections/Recruitment Rountable

P r e s e n t a t i o n : Collections/Recruitment Roundtable D i s c u s s i o n

D e s c r i p t i o n : Join us for an open forum to discuss collections/re c r u i t-ment topics relevant to YOU!

O b j e c t i v e s : 1 . Discuss and learn about current topics being dealt with at various locations.


10:15 - 11:45 AMBaton Rouge East

M o d e r a t o r : Lisa Fults, MT (ASCP)

Manufacturing Based Upon Historical Ordering Practices

S p e a k e r : Patrick SaxtonTechnical SpecialistSigma Blood Systems

P r e s e n t a t i o n : Manufacturing Based Upon Historical O rdering Practices

D e s c r i p t i o n : Discussion and review of Material Require m e n t sPlanning (MRP) process for blood product inventory management.We will review the production planning and inventory control sys-tem used to manage the manufacturing processes to ensure mate-rials are available for production and products are available fordelivery to customers. The production of blood products is some-what problematic since the availability of donated blood can varybased on time of year, holidays, and the short outdate of thesep ro d u c t s .

O b j e c t i v e s : 1. Review data and analysis re q u i re d .2. Develop plan based on product type.3. Discuss overview of hospital usage impact

( o rder vs usage).1 5 1 - 1 1 8 - 1 3PACE/CME/CEU Credits: 1 . 5

11:45 - 2:15 PM – Lunch & Exhibit Hall OpenCapital Atrium

2:15 - 3:45 PMIberville A & B

M o d e r a t o r : Alice Chen, MD PhD

Talk to Me: The Reference Lab/Transfusion Service Dialogue -What Everyone Means

S p e a k e r : Cindy Steinmetz, MT (ASCP)Lead Reference Te c h n o l o g i s tL i f e S h a re Blood Centers

P r e s e n t a t i o n : Helping the Reference Lab Help Yo u

D e s c r i p t i o n : Why does my IRL ask so many questions? Why can'tI get the blood when I need it? What takes so long? Find theanswers to your questions in this session.

O b j e c t i v e s : 1 . Explain why an IRL needs patient medical i n f o rm a t i o n .

2. Describe how antibody positive units can be utilized.

3. Give an example of how genotyping can be used by the transfusion service to supply b l o o d .

S p e a k e r : L a u ro E. Guerro Jr, BS MT (ASCP)S u p e r v i s o r, Medical Te c h n o l o g i s tSt. Luke's Episcopal Hospital

P r e s e n t a t i o n : Digging Deeper When a Simple Interpretation Just Won't Do

D e s c r i p t i o n : Sometimes more than an interpretation is neededwhen an investigation report is received. See how IRL information isused by a Transfusion Service laboratory.

O b j e c t i v e s : 1. Give an example of when a Transfusion Service Laboratory may need more i n f o rmation than the interpretation provided in an investigation re p o r t .

2. Explain how information from the IRL may be used in a Transfusion Service L a b o r a t o r y .

3. List some benefits of establishing an open line of communication between the Transfusion Service laboratory and the IRL.

S p e a k e r : Mary A. Lieb, MT (ASC) SBB CQA (ASQ)D i re c t o r, Quality Sourc eBlood Systems, Inc

P r e s e n t a t i o n : Let's Talk: If I Would Have Only Known That!

D e s c r i p t i o n : This presentation will address why timely communica-tion in product needs by the transfusion service for patient care isimportant for providing quality patient care. The importance of criti-cal patient information concerning serological problem re s o l u t i o n sas well as how addition or elimination of services can impact goodcustomer service.

O b j e c t i v e s : 1. Discuss the importance of communicating additions or changes to blood needs from the blood center perspective.

2. Identify the types of information that the blood center needs to be a better partner with the transfusion service.

3. List the types of information that is essentail for quality service to hospital customers.


A

T/S

DRC

21


.................................................................................................................www.scabb.org

SATURDAY, 4/20/20132:15-3:45 PMBaton Rouge We s t

M o d e r a t o r : Ron Chavez

"A Happy Marriage: Uniting Recruitment and Donor Services"

S p e a k e r : Carla Peterson, MPADistrict Director of Donor ServicesUnited Blood Services

P r e s e n t a t i o n : S e a rching for Synergy - The Power of an Alliance Between Collections and R e c r u i t m e n t

D e s c r i p t i o n : S y n e rgy comes from the greek word synergia meaningjoint work and cooperative action. Synergy occurs in the workplace when the result is greater that what would have been thesum of the individual contributions. Let's explore together how thisp o w e rful strategy will lead to success.

O b j e c t i v e s : 1. Influence a shift in thinking of these departments as separate entities.

2. C reate levels of collaboration throughout o rg a n i z a t i o n s .

3. Emphasize importance of executing excellence and celebrating together.

S p e a k e r : Chad A. Douglas, BSHS MHSD i rector of Donor Services OperationsSouth Texas Blood and Tissue Center

P r e s e n t a t i o n : A Happy Marriage: Uniting Donor Services and Recruitment

D e s c r i p t i o n : In many centers, there is a bitter relationship that canexist between Donor Services and Donor Recruitment. This frac-t u red realationship makes little sense as both teams work for thesame end goal - a safe and dependable blood supply. So why dowe have animosity between these two departments? Many timesthis is the result of poor perception, exasperated by decisions andactions of management. Additionally a lack of understanding andtrust is another proponent of this poor relationship. In this pre s e n t a-tion one can expect to see some diff e renct practices that have ledto great sucess in thwarting many of these relationship obstacles.

O b j e c t i v e s : 1. Change the focus off numbers, removing a major obstacle.

2. P e rception is reality. Management actions speak louder than word s .

3. Yoda approach! Understanding leads to trust, trust leads to team work, team work leads to success.


2:15 - 3:45 PMBaton Rouge East

M o d e r a t o r : Garrick “Rick” Chatelain, MT (ASCP)What About the O Negs?

S p e a k e r : James Barbeau, MD, JDD i re c t o r, Transfusion MedicineLouisiana State University School of Medicine, New Orleans

P r e s e n t a t i o n : Managing Type O-Negative Blood In A Trauma C e n t e r

D e s c r i p t i o n : Hospital transfusion services must exercise both knowl-edge and judgment when managing their inventory of O-negativered blood cells. Some additional considerations arise if the transfu-sion service supports a busy trauma center. This presentation willa d d ress the key considerations for type O-negative blood manage-ment in the hospital setting.

O b j e c t i v e s : 1. Understand the concerns and challenges of trauma centers as they manage the O-negative RBC inventory.

2. Discuss the emergency blood transfusion p rotocol at our level 1 trauma center, as well as possible alternative appro a c h e s .

3. E x p l o re some as yet unanswered questions about Rh sensitization in the trauma s e t t i n g .

S p e a k e r : Francis R. Rodwig Jr., MD MPHMedical Dire c t o r, Transfusion MedicineOchsner Health System

P r e s e n t a t i o n : W h e re are the O Negs? - Donor Center

D e s c r i p t i o n : G roup O, Rh-negative Red Blood Cells are a pre c i o u sre s o u rce that must be managed appropriately. In this section, theclose integration between the Donor Center and the Tr a n s f u s i o nServices will be discussed, including strategies and communicationbetween the two.

O b j e c t i v e s : 1. I n t roduce the strategies needed to manage a Blood Centers Distribution of O Negative RBCs.

2. Discuss methods to connect with Tr a n s f u s i o nServices about O Negative RBC U t i l i z a t i o n .

3. Review the available literature on clinical outcomes when utilizing these strategies.

S p e a k e r : J e remy HimelTe l e recruiting ManagerThe Blood Center

P r e s e n t a t i o n : What About the O Negs?

D e s c r i p t i o n : This presentation will discuss techniques used in therecruitment of O negative blood donors. Includes phone banke fforts, direct mail and donor events. Presentation of successfule fforts, and those which did not produce a re t u rn on investment.

O b j e c t i v e s : 1. Discuss successful telerecruitment of O neg d o n o r s .

2. Discuss recruitment of O neg donors t h rough direct mail.

3. D i ff e rentiate O neg donors without alienating the others.


A

DRC

23


.................................................................................................................www.scabb.org

SATURDAY, 4/20/20133:45 - 4:00 PM – BREAK: Sponsored by Abbott Laboratories


M o d e r a t o r : Garrick “Rick” Chatelain, MT (ASCP)

Ask The ExpertsS p e a k e r : Rebecca Bullock, MT (ASCP) SBB

Technical Dire c t o rQuotient Biodiagnostics

S p e a k e r : Alice J. Chen, MD PhDMedical Dire c t o r, Molecular Pathology Section; Associate Medical Dire c t o r, Blood Donor Pro g r a mSt. Luke's Episcopal Hospital

S p e a k e r : Susan Johnson, MSTM MT (ASCP) SBBD i re c t o r, Clinical EducationBlood Center of Wi s c o n s i n

S p e a k e r : Daniel K. Noland, MD FCAPMedical Dire c t o r- Transfusion and Tissue Service, Assistant Pro f e s s o rC h i l d ren's Medical Center Dallas, UTSW

S p e a k e r : Carla Peterson, MPADistrict Director of Donor ServicesUnited Blood Services

S p e a k e r : Chad A. Douglas, BSHS MHSD i rector of Donor Services OperationsSouth Texas Blood and Tissue Center

S p e a k e r : James Barbeau, MD, JDD i re c t o r, Transfusion MedicineLouisiana State University School of Medicine

1 5 1 - 1 2 2 - 1 3PACE/CME/CEU Credits: 1.0

5:45 - 6:15 PM – SCABB Annual Business MeetingA s c e n s i o n

SUNDAY, 4/21/20138:30 - 10:00 AMIberville A & B & C


Technical/Scientific Award LecturerS p e a k e r : Susan T. Johnson, MSTM MT (ASCP) SBB

D i re c t o r, Clinical EducationBlood Center of Wi s c o n s i n

P r e s e n t a t i o n : S e rologic Strengths - Limitations in An Automated Age

D e s c r i p t i o n : Detecting antigens (blood typing) and antibodies inp retransfusion testing continues to be the benchmark testing forpatients requiring blood transfusion. The success of serology cannotbe denied. Automation has provided improved testing eff i c i e n c i e sand consistent test results. However, there are situations in whichs e rologic testing, whether automated or manual, does not pro v i d eall the answers. Advantages and limitations of this testing will be dis-cussed. A call for help in resolving confusing test results (S.O.S.) willbe sent out.

O b j e c t i v e s : 1. Discuss the strengths and limitations of s e rologic testing in blood typing and antibody d e t e c t i o n / i d e n t i f i c a t i o n .

2. Examine testing methodologies utilized in automated platforms and discuss their advantages and limitations.

3. List blood group specificities with unique reactivity using diff e rent serologic m e t h o d s / re a g e n t s .

Administrative Award LecturerS p e a k e r : Mary Beth Bassett, BS MT (ASCP)

Executive Vice President, Chief Quality Off i c e rBlood Systems

P r e s e n t a t i o n : Two Sides of the Same Coin…The Business of Quality AND the Quality of Business

D e s c r i p t i o n : During this lecture you will hear why the business ofquality and the quality of the business are one and thes a m e … Two Sides of the Same Coin. You will learn why the quali-ty discipline must become woven into the fabric of the businessand why this is key to quality's future. Finally, the speaker will pro-vide the quality "wishlist" to make this happen.

O b j e c t i v e s : 1. Define the business of quality.2. Describe applications for expanding quality

into the business model.3. Implement actions to evolve quality into

your business model.1 5 1 - 1 2 3 - 1 3PACE/CME/CEU Credits: 1 . 5

10:00 - 10:15 PM – BREAK: Sponsored by Abbott Laboratories

10:15 - 11:30 AMIberville A & B & C


Karen Williams Memorial Lecture, endowed by NovartisS p e a k e r : Mark E. Bre c h e r, MD FCAP

Chief Medical Off i c e r, Senior Vice Pre s i d e n tLaboratory Corporation of America

P r e s e n t a t i o n : Bacterial Contamination of Blood Pro d u c t s

D e s c r i p t i o n : Bacterial contamination of blood components hasbeen a persistent problem since the early days of transfusion medi-cine. This has been particularly true for platelets, which are main-tained at a temperature that allows the growth of a variety of bac-terial organisms. This presentation will review the history, the science,the politics and successes and failures of our attempts to minimizethe risk of bacterial contamination of the last 25 years.

O b j e c t i v e s : 1. Review the history of bacterial contamination of blood pro d u c t s .

2. Review methods to prevent or minimize bacterial contamination of blood pro d u c t s .

3. Review the impact of actions taken to minimize the risk of bacterial contamination of blood pro d u c t s .


A T/S DRC

A T/S DRC

A T/S DRC

Join our expert panel on April 20th at 4PM wherethey will offer answers to the questions that matterto you and your organization and give you newideas you can implement tomorrow!

Submit your questions at www.scabb.orgor at the registration desk.

P rotégés and mentors, past and present, are encouraged to attend these activities. New and graduating protégés areexpected to attend the listed events, including at least one of the board meetings.

The Protégé Mentorship Program is another way in which South Central fulfills its educational mission. It helps promote goodwilland professional collaboration among the association members, while exposing members to opportunities for association serv-ice (special projects, abstract submissions, moderator duties, committee membership, board service, etc.).

All members: Please introduce yourself to the protégés as you see them throughout the meeting. They will be wearing specialP rotégé ribbons on their meeting badges.

Congratulations to the 2012-2013 Graduating Protégé Mentorship Class!

Pre-co nve ntion Bo a rd of Dire ctors Me e t i n g We d n e s d ay, Ap ril 17 • 4:00 – 7:00 pm

Membership & Pro tégé Mi xe r Th u r s d ay, Ap ril 18 • 3:15 – 4:00 pm

We l come Re ception & Exhibit Hall Opening Th u r s d ay, Ap ril 18 • 6:00 – 8:00 pm

Lunch in Exhibit Hall Fri d ay & Sat u rd ay, Ap ril 19th & 20th(Tables Re s e rved for Pro tégés & Me nto r s )

Wine & Cheese Re ception in Exhibit Hall Fri d ay, Ap ril 19 • 4:15 pm – 6:00 pm

Pre s i d e nt’s Re ception and Awa rd Ce re m o ny Fri d ay, Ap ril 19 • 6:30 pm – 10:00 pm(Old Gove rn o r’s Ma n s i o n )

Annual Business Me e t i n g Sat u rd ay, Ap ril 20 • 5:45 pm – 6:15 pm

Po s t-Co nve ntion Bo a rd of Dire ctors Me e t i n g S u n d ay, Ap ril 21 • 12:30 pm – 3:15 pm

Protégé Mentor

Sandy Wo rtman, MT (A S C P ) S B B C h e ri Jennings, MT (A S C P ) S B B, CQA (A S Q)

Ryan Nobles, MT (A S C P ) S B B Joann Mo u l d s, Ph D, MT (A S C P ) S B B

C h risti Bro o k s, MA, MT (ASCP), CQA (A S Q) Jeannie Ga rd n e r, RN

Autumne Pri ce, MT (A S C P ) S B B Sa rah Jones, MT (A S C P ) S B B

Alan Brown, MD B a rb a ra Brya nt, MD, MT (A S C P ) S B B

25

SCABB Protégé & Mentor Program

.................................................................................................................www.scabb.org

Protégé Mentor

Amanda Barz a k, MLS (A S C P )c m C h e ri Jennings, MT (A S C P ) S B B, CQA (A S Q)

L a u ro Guerra Jr, BS, MT (A S C P ) Joann Mo u l d s, Ph D, MT (A S C P ) S B B

Yasmine Ki n g Diane Lechuga, MT, BB (A S C P )

C l i nt Huff Kathie Ca rlson, MT (A S C P ) S B B

Welcome to the Incoming 2013-2014 Protégé Mentorship Class:

26www.scabb.org

President’s Award of Merit: Outstanding Individual

The President's Aw a rd ofMerit to an OutstandingIndividual is presented toan individual who hasmade a significant contri-bution to the bloodre s o u rces of a blood col-lection facility. This year’sa w a rd goes to an out-standing couple – Jamesand Christine Rollins. Jimbegan donating blood incollege. He marriedChristine, his high schoolsweetheart in 1976.

Christine donated blood for the first time while attendingWa y n e s b u rg University for a patient that had been in a car acci-dent. They continued to donate blood in Baton Rouge with OurLady of the Lake Regional Medical Center. In 2006, Jim andChristine became regular platelet donors. They donate themaximum number of times that a platelet donor is allowed todonate every year. Understanding the huge need for blooddonors, they set up regular blood drives at Highland Pre s b y t e r i a nC h u rch. They encourage all parishioners to donate and set theexample by rolling up their own sleeves. Christine has now setup blood drives at Woodlawn Elementary School during theyearly health fair. This power couple has donated 418 aphere s i sp roducts and 61 whole blood donations and together theyhave hosted 19 blood drives yielding 403 apheresis donationsand 261 whole blood units. Outstanding!

President’s Award of Merit: Outstanding Contribution

The President’s Aw a rd of Merit forOutstanding Contribution is presented toa group whose contributions to the bloodbanking profession have shown spectac-ular long or short-term results. Petro l e u mHelicopters, Incorporated (PHI) is award-ed the President’s Aw a rd of Merit for ded-ication to the cause of blood donation.PHI has been a top-perf o rming blooddonor group with Our Lady of Lourd e s

Regional Medical Center since 1990. Lourdes Blood Center hasbeen fortunate to have formed a strong bond between itsemployees and PHI employees. PHI has committed to hostingfour drives a year for a total of 8 days per year. In 2008, theyi n c reased the number ofdrives to five two-day drives ayear to ensure that allemployees have the opportu-nity to donate. PHI employ-ees have amassed over 8,000blood donations at 194 drivesover 23 years. PHI goesabove and beyond to bolsterthe community blood supply.

27

And the Award Geauxs to……..

.................................................................................................................www.scabb.org

President’s Reception & Awards Banquet

The Old Governor’s Mansion is a historic house museum listed on the National Register of Historic Places. Built in 1929 by the “Kingfish,”Huey P. Long, the Mansion served as Executive Residence from 1930 until 1963 and housed nine of Louisiana’s governors including EarlK. Long and the “singing govern o r,” Jimmie Davis. The Mansion will serve as the perfect venue to host the Aw a rds Banquet as we honorour donors and many others on Friday, April 19th beginning at 6:30 pm. Pre-registration required.

Larry L. Trow Memorial Educational Award

The Larry L. Trow Memorial EducationalAw a rd is presented to an individual whohas significantly contributed to the pro m o-tion of immunohematology education attheir employing institution and at thelocal, state, and regional levels. Dr.Barbara Bryant, nominated while she waswith the UTMB Blood Bank and SBB pro-gram, is awarded the Larry Tro wEducational Aw a rd. Dr. Bryant is a ro l emodel for teachers and for anyone who

wants to make blood banking their life’s work. Her teachingresponsibilities include pathology residents, medical students, a

PhD candidate student, masters and BS students in CLS, and SBBstudents. Dr. Bryant’s educational style is to lead and nurture thestudent to make their own discoveries. With her help, the SBBstudents have been awarded scholarships for their re s e a rc h ,published papers and AABB abstracts. This year with her leader-ship and teaching, the two CLS student’s re s e a rch paper wasaccepted as an oral presentation at AABB. She has encour-aged pathology residents to go into Clinical Pathology andspecifically transfusion medicine. She is respected by everyonewho has ever had the pleasure to work with her. In her sparetime, Dr. Bryant is on committees and lectures for AABB andSouth Central Association of Blood Banks. She was recently invit-ed to speak in Europe about her iron studies in donors. Dr. Bryanthas the most amazing enthusiasm for life, teaching, and transfu-sion medicine.

28

And the Award Geauxs to……..

www.scabb.org.................................................................................................................

Dr. Matthew Gottlieb Rising Star Award

The Dr. Matthew Gottlieb Rising StarAw a rd is presented to a new individualmember who has made significant contri-butions and shown a strong commitmentto the South Central Association of BloodBanks in a short period of time. LaraT h e d f o rd, of Peterson Regional MedicalC e n t e r, is awarded the Rising Star Aw a rdfor her incredible jump start into ourAssociation. Lara joined in 2009 and

attended her first annual meeting in San Antonio. She immedi-ately became very involved. Lara was a Protégé in 2010. Shegraduated at the Las Vegas meeting in 2011. As a protégé shejoined the Technical Scientific Committee and was veryinvolved with finding speakers and topics for the TS sessions.After the Vegas meeting, Lara remained on the Te c h n i c a lScientific Committee and also joined the Aw a rds Committee. Atthe Austin SCABB meeting, Lara presented at a Te c h n i c a lScientific session on 'When Antibodies Don’t Read the Book, aCase Study”. She is currently the co-chair of the Te c h n i c a lScientific Committee and has encouraged new members fro mher hospital to join the Association. Lara pays her own way toannual meetings and interim summer board meetings and takesvacation time to attend because her hospital has limited edu-cation funding. In a short amount of time, Lara’s commitmenthas proven her to be a Rising Star.

The Cornerstone Award

The Cornerstone Aw a rd is presented toan individual or institutional member ofthe association who has contributed inan extraordinary way to the success ofthe South Central Association of BloodBanks. Chris Coffin, of United BloodServices, is awarded the Corn e r s t o n eAw a rd for his cumulative 35 years ofe x t r a o rdinary contribution to the gro w t hand prosperity of the South CentralAssociation of Blood Banks. Vo l u n t e e r s

a re the only reason our association has existed for 55 years andChris has been one of the most active volunteers for 35 of thosey e a r s . Since 1977, Chris has served on many committeesincluding the Donor Room/Donor Recruitment Pro g r a m ,Administrative Program, Technical/ Scientific Program, Exhibits,Publications, and Membership. He served on the Board for atotal of 11 years, including 6 years in the position of Tre a s u re rand a term as President in 2003. He has helped select our asso-ciation leaders by acting as chair of the Nominating Committeeon three separate occasions including this year. He has beenon the Protégé Mentorship Program Committee since its incep-tion in 2005. He helped to grow the program from an idea to am a t u re mentoring program and also served as a mentor for twoof our protégés. He served on the Foundation Board for fiveyears from 2005 to 2010. Chris has a solid resume of sustainedservice and it is hard to imagine where we would be without hish a rd work and guidance over the years. Our organization needsour experienced members to remain active and share the wis-dom of their historical perspective on association business andtheir years of experience in our industry. Chris is an example tous all of long term commitment and the significant contributionone person can make. Chris Coffin is truly a cornerstone of ourbeloved South Central Association of Blood Banks.

Sol Haberman Scholarship Award

This award is presented to a student of ana p p roved or accredited SBB pro g r a ma n y w h e re within the United States in honorof Sol Haberman and his pioneering workin blood group immunology.

Michael Scabet, MT (ASCP)P recision of Antibody Titration in Gel versusTube is the 2013 Sol Haberman Scholarship

w i n n e r. Michael will present his paper on Saturday, April 20that 8:45am in the Iberville Room of the Belle of Baton RougeHotel. As this years recipient Michael receives a certificate ofmerit, $300.00 scholarship check, and complimentary fullmeeting registration to this year’s meeting. Michael earn e dhis SBB through the Gulf Coast SBB program and now servesas Technologist in the Consultation and Refere n c eLaboratory at Biloxi Regional Medical Center.

View Michael’s paper in its entirety on www.scabb.org

29

2013 ABSTRACT JOURNAL GRID

.................................................................................................................www.scabb.org

ORAL PRESENTATIONSOral Presentations will be presented in the Iberville Room,

Saturday, April 20th at 8:45 am

# Time Abstract Title ProgramCategory

8:45 AM SCABB Sol Haberman Award WinnerP recision of Antibody Titration in Gel versus Tu b e

1 9:00 AM Is Molecular Typing More Accurate than Sero l o g yfor Blood Group Determination in a Donor Population?

5 9:15 AM Evaluation of Platelet Progeny Production During Blood BankStorage Conditions

8 9:30 AM Comparison of Antibody Titers in Donor Specimens and AssociateAS-1 Leukocyte-Reduced Donor Units

9 9:45 AM Rapid Thaw Plasma: As Good As the Regular Stuff But Faster

POSTER PRESENTATIONSPosters may be viewed outside of the Exhibit Hall throughout the Annual Meeting.

# Time Abstract Title ProgramCategory

2 A Case of Primary Peritoneal Carcinoma with Anti-Yo ParaneoplasticS y n d rome Treated with Plasmaphere s i s

3 Development of TaqMan Genotyping Assays for 38 Genetic Va r i a n t sf rom 17 Blood Group Systems

4 RBC Genotyping Success in a Chronically Transfused Patient with Multiple Prior Antibodies

6 Unexpected Antibodies and Leukocyte-Reduction Failure s :Trends in Red Blood Cell Wa s t a g e

7 An Investigation of Non-ABO Group Specific Platelet Tr a n s f u s i o nPractices in US Blood Banks

1 0 Initiatives to Reduce Reaction Rates in Young Blood Donors

1 1 Transfusion of Group O Red Blood Cells to Non-Group O Recipients:Analysis and Assessment of Practice

1 2 Blood Inventory Management: A Look at How to Control the AntigenNegative and Rare Unit Inventory

1 3 Laboratory Workflow Efficiency Improvements After Implementation of aFully Automated Immunoassay Analyzer

1 4 S t a n d a rdizing Whole Blood Laboratory Production withSix Sigma and LEAN Manufacturing

T/S

T/S

T/S

T/S

T/S

T/S

T/S

T/S

T/S

DRC

T/S

DRC

T/S

T/S

30

2013 ABSTRACT JOURNAL

www.scabb.org.................................................................................................................

SOL HABERMAN ABSTRACT

ABSTRACT TITLE: P recision of Antibody Titration in Gel verses Tu b e

ABSTRACT AUTHOR: Michael Scabet, MT(ASCP)

B A C K G R O U N D : The titration of an alloantibody to a red cell anti-gen is a useful semi-quantitative screening tool that, when com-p a red to a previous titer perf o rmed by the same technique, candetect an increased production of maternal antibody duringp regnancy. The currently accepted titration methodology is thetube method; titration using the gel column method may re s u l tin higher titer results. This study compared gel titration and tubetitration for precision as an indicator of which method can moreaccurately predict a true rise in titer as compared to a variationdue to technique.

STUDY DESIGN AND METHODS: A total of 42 samples containingIgG red cell antibodies were evaluated for both antibody titerand titration score. Serial two-fold dilutions of plasma weremade in normal saline. From each master dilution, 100 ÌL wasused for tube testing and 25 ÌL was used for concurrent titrationin gel. Each sample was tested a total of 3 times, on diff e re n tdays, by each titration method. Plasma samples were store df rozen between test days.

R E S U L T S : T h e re was no diff e rence in antibody titer in any givensample when testing was repeated on that sample by gelmethodology. Of the titers perf o rmed in tube, 7 of 42 (17%)showed a diff e rence in titer of 1 dilution when repeating testingon the same sample. There was no diff e rence above one titra-tion dilution. While only 7% of titrations in gel demonstrated slightchanges in titration score, 28% of the tube titers demonstratedslight changes. None of the changes in scores was above 10.The precision of repeat titer results perf o rmed in gel was slightlym o re consistent (p = 0.0095) when compared to tube titration.The precision of titers in tubes was low to moderate. When theantibody titer was higher, there was a more discernible diff e r-ence between the precision of the two methods.

C O N C L U S I O N : Results of this study demonstrated that more vari-ation in antibody titration and titration score were noted uponrepeat testing of the same sample when testing was perf o rm e din tubes as compared to repeat testing in gel. A diff e rence intiter and/or score based solely on the precision of the methodol-ogy utilized, in conjunction with a true rise in antibody titer in asubsequent sample, could lead to inconclusive or misleadingresults when the antibody titer has truly risen significantly.Although the titers and scores in gel are higher than tubes, per-f o rming antibody titration using gel technology is worth seriousconsideration and validation in a laboratory using gel technolo-g y .

ABSTRACT #1

ABSTRACT TITLE: Is Molecular Typing More Accurate thanS e rology for Blood Group Determination in a Donor Population?

ABSTRACT AUTHORS: Joann Moulds PhD, MT (ASCP) SBB; NoumsiG T; McCaskill D; Hendrix J

I N T R O D U C T I O N : C u r rently the “gold standard” for blood gro u pd e t e rmination is based on serological re a g e n t s . H o w e v e r, theimplementation of molecular methods for blood grouping hasraised the question as to which is the most accurate method.Thus, we studied a group of either African-American or Native-American blood donors by both methods to determine theiroverall accuracy.

MATERIALS & METHODS: A total of 2,502 samples (32,526 anti-gens) were tested using FDA licensed antisera and by micro a r-ray (HEA, BioArray Solutions). Antigens tested included Cc, Ee,K1, Fya/Fyb, Jka/Jkb, MN, and Ss. Samples that initiallya p p e a red discordant were repeated with a second source ofantisera and a second molecular method. Some samples wereDNA sequenced to resolve the discrepancy. Results: A total of12 samples (0.48%) were investigated due to conflicting re s u l t s .This re p resented an error rate of only 0.037% for the total numberof antigens typed. Ten of the 12 samples re q u i red DNAsequencing to determine the final cause for the differing re s u l t s .The antigens that were discordant included: 4 S, 2 s, 2 E, 1 e, 1 c,1 Jka and 1 Jkb. When the serology was repeated with a diff e r-ent manufacturer’s reagent, five of the 12 samples gave re s u l t sthat were now concordant with DNA. For the two little s dis-c repancies, two diff e rent mutations were found in the GPBgenes: the first affected primer binding (false negative DNA)and the second caused an Arg35His change that affected anti-body binding (false negative sero l o g y ) . For the RHCE genes, a new SNP (221G>A) causing a gene deletion was found in thetwo E cases. The little c and little e discrepant samples werefound to have variants known to produce weak RH antigens(ceMO, ceJAL) which resulted in false negative serological typ-ings. A new silencing mutation was found for the JK*A gene(866A>G).

C O N C L U S I O N: D i s c o rdant results between serological and DNAbased methods for blood grouping are very rare . M o re impor-tantly, our study has shown that contradictory results may beobtained even when using licensed antisera for typing. T h epossibility of mis-typing a sample due to a new DNA mutation inour population was only 0.021% and may be even lower in aCaucasian population.

T/S (ORAL)


ABSTRACT #2

A BSTRACT TITLE: A Case of Primary Peritoneal Carcinoma withA n t i - Yo Paraneoplastic Syndrome Treated with Plasmaphere s i s

ABSTRACT AUTHORS: Leslie Jo Greebon, MD; Chantal Harrison

B A C K G R O U N D : Paraneoplastic syndromes (PNS) are rare disor-ders that are triggered by an altered immune system response to a malignancy. Collections of symptoms result fro msubstances produced by the tumor including hormones, hor-mone precursors, enzymes, cytokines, and anti-bodies to neu-ronal antigens. Symptoms usually appear when cancer is still inits early stages and often undetectable. Anti-neuronal antibodies are specific to a group of clinical syndromes andtumor types suggesting a potential site of underlying cancer.

MATERIALS AND METHODS/ CASE REPORT: A 66 year old femalep resented 3/2010 with abdominal bloating and discomfort forseveral months. She had a subcutaneous nodule in her anteriorabdominal wall which was fine needle aspirated and re p o r t e das “Malignant cells present, favor poorly diff e rentiated carc i n o-ma”. A CT scan done on 3/2010 of the abdomen and pelvisrevealed hickening of the omentum and peritoneal lining of thepelvis consistent with carcinomatosis. With an elevated CA 125of >11,000 she was clinically diagnosed with primary peritonealc a rcinoma/Ovarian carcinoma and subsequently underwentchemotherapy. She appeared to have no evidence of diseaseon imaging one year later (3/2011). In 5/2012 there was ani n c rease in CA-125 form <10 to >300. In 6/2012 she pre s e n t e dwith one month of pro g ressive dizziness, ataxia, dysarthria, anddouble vision consistent with subacute cerebellar degeneration.

O B S E R V A T I O N S : Based on the constellation of symptoms, apanel of anti-neuronal antibodies was perf o rmed and Anti-Yoantibody was positive. Anti-Yo is associated with the clinical syn-d rome of subacute cerebellar degeneration and is most com-monly reported with ovarian and breast cancers.

P l a s m a p h e resis for paraneoplastic syndromes is a class III tre a t-ment indication (may be beneficial but not enough evidence).Five single volume plasmapheresis were attempted which werecomplicated by low access pre s s u re and patient anxiety.A p p roximately 4 volume exchanges were perf o rmed within 9days. The patient’s dysarthria improved mildly. There was noother noted improvement in motor function.

D I S C U S S I O N : Review of literature reveals 8 case reports of paraneoplastic syndromes treated with plasmapheresis. Fivecase reports involved Anti-Yo. When noted in the study 5% albu-min with single volume replacement and various tre a t m e n tschedules were perf o rmed. Six studies demonstrated various lev-els of improvement in motor function initially with gradual non-responsiveness and termination of further pro c e d u res. Two stud-ies did not demonstrate any clinical improvement at any point intime. Our patient demonstrated mild improvement in speech ini-tially. Plasmapheresis in the treatment of paraneoplastic syn-d rome secondary to anti-neuronal antibodies could be benefi-cial but further studies are needed (Class III indication).

Abstract #3

ABSTRACT TITLE: Development of TaqMan Genotyping Assays for38 Genetic Variants from 17 Blood Group Systems

ABSTRACT AUTHORS: Meihong Liu, PhD; Te resita Merc a d o ;Zhugong Liu

B A C K G R O U N D : The traditional serological assays serve the trans-fusion field well for the major blood types. However, in cases ofantibodies with decreased availability or red blood cell (RBC)antigens or antibodies with weak reactivity, molecular assayso ffer a good alternative. Molecular assays use genomic DNAand thus can be used to type recently transfused patients aswell as patients with warm autoantibodies. Furtherm o re, bloodg roup molecular typing assays are more amenable to thedevelopment of high-throughput platforms than serological typ-i n g . We have developed TaqMan genotyping assays to pre d i c tthe expression of RBC antigens.

STUDY DESIGN AND METHODS: Using the TaqMan real-time geno-typing platform (Applied Biosystems), we designed 23 customassays; these assays, together with 15 predesigned assays, wereused to detect 38 genetic variants (including single-nucleotidepolymorphism, insertions and deletions) encoding 56 antigens from 17 blood group systems. These clini-cally significant blood group polymorphisms were selectedbased on AABB’s recommendation in the Molecular Te s t i n gS t a n d a rds. Bi-directional sequencing assays were used to confirm the results generated by the TaqMan assays.W h e re available, the phenotype obtained by serologic testingwas compared to genotype data.

R E S U L T S : The sequences of all 38 polymorphisms were verifiedand the association of each allele to the encoded blood gro u pantigen was confirmed by carefully re f e rencing NCBI dbRBC,dbSNP and the original reports. The nontarget polymorphisms inthe context genomic sequences were also considered to assurethe assays quality. TaqMan real-time genotyping platform allows us to successfully design thep r i m e r / p robe sets for most targets. However, a few pre - d e s i g n e dor custom designed assays by the program, including K/k, Joa, Ssilence (nt230C>T), and DIa/DIb, initially failed to make accept-able genotype calls. More pre-typed samples that cover thre etypes of genotype (homozygous allele one or two, and het-e rozygous) are re q u i red to validate the assays. In addition, chal-lenges were met in designing assays for detection of the 37bpinsertion (RHD„) and the 109 bp insertion (RHC). Two assays arere q u i red for each insertion, and additional steps are re q u i red todistinguish heterozygous from homozygous haplotype.

C O N C L U S I O N : We established and tested a set of TaqMan re a l -time genotyping assays to detect 38 clinically significant bloodg roup polymorphisms. These assays are used to support the cre-ation of DNA re f e rence panels for blood group molecular typingd e v i c e s .

T/ST/S

31 .................................................................................................................www.scabb.org


Abstract #4

ABSTRACT TITLE: RBC Genotyping Success in a Chro n i c a l l yTransfused Patient with Multiple Prior Antibodies

ABSTRACT AUTHORS: August Moritz, DO; Chantal Harrison, MD

B A C K G R O U N D : The application of molecular genotyping totransfusion medicine has the potential to predict patient pheno-types and direct the selection of blood for transfusion. We pre s-ent a case report of a chronically transfused patient with the apparent development of multiple antibodies in conflict withthe results from a genotype analysis.

CASE REPORT: AS is a 24-year-old South Asian woman with a his-tory of thalassemia major who has been transfusion dependentsince infancy. The patient has had multiple complications fro mher disease which include hyperparathyroidism, short stature ,h y p o g o n a d o t ropic hypogonadism, impaired glucose tolerance,and osteoporosis. The patient also has cardiac manifestations ofi ron overload from the re c u r rent transfusions. She moved to theUnited States in August of 2010 and has since received herblood transfusions at the same institution. Over the past 24months, she appeared to have developed multiple antibodies:8/25/10: A n t i - K8/24/11: Anti-K, Anti-e11/17/11: Anti-K, Anti-e, Anti-C (with positive DAT with

Anti-e and Anti-C in eluate on two occasions)1 / 4 / 1 2 : Anti-K, Anti-e, *Suspected Anti-S

but never confirmed1 / 1 7 / 1 2 : Anti-K, Anti-e, Anti-C, *Suspected Anti-S

but never confirmed8/29/12: Anti-K, Anti-Kpa, Anti-V9/11/12 topresent: Anti-K onlyCompatible anti-K,e,C, and S negative blood was transfused tothe patient for the past year. Due to transfusion dependency,the patient could not be typed with standard serologic meth-ods. Genotyping for RBC was recommended for the accurateidentification of antigens to help guide the choice of compati-ble RBC units and to perhaps prevent additional antibody for-mation.The patient's RBC genotype, perf o rmed on 11/18/2012using Bioarray Beadchip technology, implied expression of C, e,and S antigens. We recommended transfusing the patient withphenotype/genotype matched blood. Since 12/31/12, thepatient has received three units of K antigen negative and Eantigen negative blood. Her most recent (1/22/13) antibodys c reen was only positive for Anti-K antibody, with a negativeD AT.Upon exhaustive review of the serologic workups, it appearsthat the aforementioned Anti-e and Anti-C antibodies werep resent. The significance of this is unclear. The antibodies couldbe autoimmune as the patient was found to be C and e posi-tive by genotypic analysis. The patient's medications were nota l t e red during this timeframe, but she reportedly had the influen-za vaccine in the fall of 2011. There have been case reports ofinfluenza vaccine immediately preceding the generation ofautoantibodies, including antibodies reportedly to have causedhemolytic anemia. Another possibility includes an uncommon Rhgenotype. Sequencing of the RhCE gene was re c o m m e n d e d .

C O N C L U S I O N : RBC genotype was helpful in predicting compat-ible blood in a chronically transfused patient with thalassemiam a j o r. This effectively increased the available units from a p p roximately less than 1% to 70%.

Abstract #5

ABSTRACT TITLE: Evaluation of Platelet Progeny Pro d u c t i o nDuring Blood Bank Storage Conditions

ABSTRACT AUTHORS: Barbara Bryant, MD, MT(ASCP)SBB; Ruth Kent; Amanda Spicer

B A C K G R O U N D: Recent studies suggest platelet counts ofplatelet units may increase during blood bank storage due tothe production of platelet progeny. Platelets have the abilityto produce another platelet within a six hour time frame, and this replication may occur during storage for up to ten days.P rogeny exhibit structural and functional characteristics simi-lar to their parent counterparts. Platelet progeny form a t i o nresults from the platelets’ ability to continue protein synthesis,and increase biomass and intracellular protein. This study evaluates platelet counts of blood bank donor platelet con-centrates during standard blood banking storage conditions.

M E T H O D S : Random whole blood (WB) derived platelet unitsw e re selected for this study. Platelet units were stored underroutine blood bank storage conditions, and platelet countsw e re measured on days 1, 6, and 10 post-collection.Statistical analysis was perf o rmed using the Student’s t-testwith significance defined as p value < 0.05.

R E S U L T S : Platelet counts of 20 WB derived platelet units weree v a l u a t e d . Average platelet counts x1010 (± standard devi-ation) were 6.6 (± 1.3), 7.1 (± 1.4) and 7.3 (± 1.6) on days 1, 6,and 10, re s p e c t i v e l y . T h e re was no overall statistical signifi-cance in platelet counts between days 1 and 6, days 6 and10, and days 1 and 10 (p = 0.2, 0.7, and 0.1, re s p e c t i v e l y ) .H o w e v e r, statistical significance was noted between thedeltas of days 1-6 and 6-10 (p = 0.002) and days 6-10 and 1-10 (p = 0.0003), but not days 1-6 and 1-10 (p = 0.140).

A subset analysis was perf o rmed excluding 4 platelet unitsthat did not meet the quality control re q u i rement of aplatelet concentration of 5.5 x 1010. In the subset analysis,the average platelet counts x1010 (± standard deviation)w e re 7.1 (± 0.7), 7.7 (± 0.7) and 7.9 (± 0.9) on days 1, 6, and 10, re s p e c t i v e l y . T h e re was overall statistical significance inplatelet counts between days 1 and 6 and days 1 and10 (p= 0.03 and 0.01, respectively). Statistical significance wasnoted between the deltas of days 1-6 and 6-10 (p = 0.008)and days 6-10 and 1-10 (p = 0.0004), and approached signifi-cance for days 1-6 and 1-10 (p = 0.070).

C O N C L U S I O N : Platelet counts of platelet concentrate unitss t o red under routine blood bank conditions increased up to10 days post-collection. Additional studies are warranted toc o n f i rm the platelet progeny are viable, and if the incre a s e sin platelet concentrations documented in this study couldpotentially have an impact in the blood banking community.The advent of new platelet additive solutions that wouldextend the storage time of platelets could prove advanta-geous when coupled with platelet progeny production. Thiscould potentially lead to platelet concentrates with extend-ed storage times and thus the opportunity for higher plateletcounts per unit at the time of transfusion.

T/S T/S (ORAL)

32www.scabb.org.................................................................................................................


Abstract #6

ABSTRACT TITLE: Unexpected Antibodies and Leukocyte-re d u c-tion Failures: Trends in Red Blood Cell Wa s t a g e

ABSTRACT AUTHORS: Barbara Bryant, MD, MT(ASCP)SBB; Lina Russell; Kyle Ivy; Charity Wo o d

IN T R O D U C T I O N : Blood centers frequently discard red blood cell(RBC) units from donors with positive antibody screens andrepeat leukocyte-reduction (LR) filtration failure s . The AmericanAssociation of Blood Bank (AABB) Standards do not specify pro-c e d u res that must take place for the disposition of donor unitswith positive antibody screens or repeat LR filtration failures, butleave those decisions to the donor centers as defined in theirs t a n d a rd operating pro c e d u re (SOP). These causes of donorRBC wastage re p resent potential loss of donors from which tocollect units. A survey of national blood centers was perf o rm e dto determine policies and practices pertaining to these issues.

M E T H O D S : The survey was designed to assess the disposition ofRBCs with positive antibody screens and pro c e d u res employedwhen LR filtration failure occurred. The survey was pre d o m i n a n t-ly multiple-choice format with room for specific data when“other” was designated. It was conducted online over a 25 day period and administered to a convenientsample of national blood centers across the United States.

R E S U L T S : Thirty-five surveys with responses re g a rding positive donorantibody screening were received. Responses to LR questionsw e re completed in 33 surveys. The majority of blood centers(74%) reported <25 positive antibody screens per month followedby 14% with >50, and 11% with 25-50. RBC units were labeledwith the identity of the antibody or labeled to be transfused aswashed RBCs by 77% of the donor centers. Additional testing wasp e rf o rmed and further actions dependent on these results weretaken at 6% of the facilities, and 17% of the centers disposed ofthe units. The majority of blood centers (73%) reported <5 LR fail-u res per month with the remaining centers equally distributedamong the 5-10, 11-20, and >20 categories. When encounteringa LR failure, 88% of the facilities disposed of the unit, 6% used theunit as non-LR, and 6% responded with actions that were highlydependent on quality control measures. Sickle cell solubility test-ing following LR failure was perf o rmed at 45% of the blood cen-ters, and 67% notified blood donors of the re s u l t s .

C O N C L U S I O N : Overall, RBC wastage was reported by 17% and88% of surveyed blood centers when the donor antibody scre e nwas positive and the units failed LR, re s p e c t i v e l y . While manyfacilities have developed SOPs that conserve RBC units withdetected antibodies, less has been done to prevent RBCwastage from units that fail LR. Disposal of these units is often unavoidable since the blood fails to passt h rough the filter in the allowable filtration time. To decre a s eRBC wastage, units from donors identified to have repeat LR fail-u res or sickle trait should not be LR until more efficient LR systemswith a lower failure rates are available or collection systems that minimize in vitro polymerization of sickle trait blooda re developed.

Abstract #7

ABSTRACT TITLE: An Investigation of Non-ABO Group SpecificPlatelet Transfusion Practices in United States Blood Banks

ABSTRACT AUTHORS: Anita Strong, MT(ASCP); Cinnamon Uptmor;Erin Taylor; Karlien Tebbetts; Barbara Bryant

B A C K G R O U N D : Platelets are often transfused without muchre g a rd to ABO compatibility. ABO incompatible plasma hasthe potential to cause hemolytic transfusion reactions (HTRs).Reducing the volume of incompatible plasma by centrifugationor washing, imposing volume per time limitations, and determ i-nation of critical titers have been employed. ABO antigen mis-matched platelet transfusions can result in lower platelet re c o v-eries. A survey of transfusion services was perf o rmed to deter-mine the policies and practices pertaining to these issues.

M E T H O D S : The survey was designed to determine institution size,characterize platelet usage, and assess transfusion practicesrelated to non-ABO group specific platelets. The survey wasp redominately multiple-choice format with room for specificdata when “other” was designated. It was conducted onlineover a 30-day period and administered to a convenient sampleof transfusion centers across the United States. Statistical analy-ses utilized the Chi Square and Fisher’s Exact Probability Te s t s .

R E S U L T S : Forty-eight survey responses were re c e i v e d . T h emajority (98%) were from hospital transfusion services (10% <100beds; 29% 101-300 beds; 36% 301-500 beds; and 23% >500 beds).One response (2%) was from a centralized transfusion service.Fifty percent transfused less than 1,000 platelet transfusions/year,and 75% of the institutions used only apheresis platelets. All but14% had policies for the transfusion of platelets containing ABOincompatible plasma. Most common policies included: volumeor volume per time limits, volume reduction of ABO-incompati-ble plasma without saline re-suspension, and the notification ofthe medical dire c t o r. Eight institutions (17%) determined the titerof Anti-A or Anti-A,B in group O platelets. Titration methodsincluded: tube (75%), gel or combination (12.5% each). Criticalantibody titers of 8, 50, 100, and 200 were re p o r t e d . I n s t i t u t i o n swith more than 1,000 transfusions/year were more likely to takeABO-antigen specificity into account in the selection of platelets (p=0.02) and reduce the amount of incompatible plas-ma when transfusing ABO incompatible platelets (p<0.05). Smallblood banks (< 500 beds) were as likely to place volume or vol-ume per time limits on ABO-incompatible platelet transfusions asl a rge blood banks.

C O N C L U S I O N : Transfusion practices varied widely in this survey.The number of platelet transfusions/year had greater signifi-cance in the formulation of policies for reducing the potential ofHTRs due to ABO incompatible plasma than the number of beds in the facility. Few facilities perf o rmed Anti-A orAnti-A,B titers of group O platelets, and there was little agre e-ment on titration methods and definition of a critical titer in thosethat did. Surveys such as this provide an educational benefit totransfusion services for formulating or re-evaluating transfusionp r a c t i c e s .

T/ST/S

33 .................................................................................................................www.scabb.org


Abstract #8

ABSTRACT TITLE: Comparison of Antibody Titers in DonorSpecimens and Associated AS-1 Leukocyte-Reduced DonorU n i t s

ABSTRACT AUTHORS: Elizabeth Hill, MT(ASCP)SBB; Barbara Bryant

B A C K G R O U N D : A c c o rding to the Standards for Blood Banks andTransfusion Services, donors with a history of transfusion or pre g-nancy shall be tested for unexpected antibodies to red cell anti-g e n s . When a donor has a positive antibody screen, their re dcell unit must be labeled as positive for the identified antibody.Such units may be sold, but frequently are destro y e d . Since AS-1 leukocyte-reduced red blood cell (LR-RBC) units are packedto remove most of the plasma, and the remaining plasma isthen diluted with a preservative solution, the titer of the unex-pected antibody may be reduced to a level deemed acceptable for transfusion. This study wasp e rf o rmed to determine the titer reduction of unexpected anti-bodies in AS-1 LR-RBC units and potential acceptability of theseunits for unrestricted transfusions.

M E T H O D S : RBCs were collected, leukocyte-reduced, and store din Adsol red cell preservative solution, AS-1. Antibody scre e n i n gof donor samples was perf o rmed using the Galileo Capture - R ,R e a d y - S c reen Pooled Cells (Immucor, Inc., Norc ross, GA), andpositive screens were confirmed with the ID-MTS Gel Te s tMethod (Ortho-Clinical Diagnostics Co., Pompano Beach, FL).Random donor samples with confirmed positive antibodys c reens over a 5 month period were selected for this study.Antibody identifications were done using PEG-IgG tube method.Antibody titers were perf o rmed by the saline tube method inparallel with donor specimens and the supernatant from theassociated donor unit segments. Titer and score results from thematched serum and supernatant specimens were compare d .

R E S U L T S : Thirty-nine donor samples with unexpected antibodiesw e re analyzed. Average antibody titer from the donor sampleswas 15 (range <1-128) with an average score of 24 (range 3-70).Average donor segment supernatant titer was 4 (range 0-32)with an average score of 12 (range 0-55). Of the 39 antibodiesdetected in donor samples, 28% (11/39) were undetectable inthe donor segment supern a t a n t .

C O N C L U S I O N : Antibody titers and scores decreased in the AS-1LR-RBC when compared to the donor specimen. All antibodiesw e re diluted by the preservative to a titer of ≤ 32. ABO anti-body titers in AS-1 group O RBC have been reported to be ashigh as 64, yet these units are frequently transfused to non-gro u pO recipients without adverse eff e c t s . Many consider an Anti-Atiter of 200 to be the clinically significant threshold for group Oa p h e resis platelets. If a “clinically significant” titer for donoralloantibodies was established, blood centers could perf o rm aone tube titer using the donor segment supernatant to deter-mine if the units were eligible for unrestricted transfusions. T h i swould decrease unnecessary RBC wastage and increase unitsavailable for transfusion.

Abstract #9

ABSTRACT TITLE: Rapid Thaw Plasma: As Good As the RegularS t u ff But Faster

ABSTRACT AUTHORS: Yasmine King, MT (ASCP) SBB, MPH; Wa l t e rLinz, MD MBA

B A C K G R O U N D : Recent studies have suggested resuscitation ofpatients requiring massive transfusion support is best accom-plished with a 1:1:1 ratio of red blood cells/plasma/ platelets.Transfusion services have been asked to provide these pro d u c t sincluding plasma within the first hour of admission. In an effort tomeet these demands, our hospital based blood center devel-oped rapid thaw plasma (RT P ) . RTP is made by sterile dockinga 2000ml Teruflex Transfer bag (Terumo Medical Corporation,Tokyo, Japan) to a plasma unit separated from a whole bloodunit collected in an IMUFLEX WB-RP Blood Bag (Terumo Medical Corporation). T h eRTP is then frozen flat in a ≤-18C fre e z e r. The large collectionbag produces a thin sheet of frozen plasma at a small incre a s e dd i rect marginal cost, but the unit can be quickly thawed in as t a n d a rd water bath. A recent study conducted by this facility,d e t e rmined the average thaw time of RTP to be 5.81 minutes, saving nine minutes in thaw time com-p a red to a conventional unit of fresh frozen plasma (FFP). Wep resent data to demonstrate that factor activity in RTP is com-parable to FFP.

M E T H O D S : A total of 10 plasma units, two units per day over afive day period, were selected for this study. One unit eachday was designated to be made into FFP and another into RT P.Seven days after collection and freezing, the units were thawedand a sample was taken from each unit. A coagulation panelconsisting of pro t h rombin time, activated partial thro m b o p l a s t i ntime, and Factor I, V, VII, VIII, and X assays were perf o rmed oneach sample using an automated coagulation analyzer(Diagnostica Stago, Inc., Parsippany, NJ). Statistical analysis oflaboratory results was perf o rmed using the Student’s T-test withsignificance defined as p < 0.05.

R E S U L T S : The mean values for (FFP/RT P ) : FI (325% ±29/284% ±28),FV (104%±15/90%±14), FVII (153%±35/174%±40), FVIII(111%±30/97%±18), FX (105%±15/111%±21), PT (11.5±0.6 sec-onds/11.3±0.3 seconds) and aPTT (30.1±1.4 seconds/29.7±1.1seconds). All results were statistically indistinguishable.

C O N C L U S I O N : RTP is an innovative modification of a standardcomponent that reduces thaw times and retains factor activitylevels equivalent to conventional FFP at a small increased dire c tm a rginal cost.

T/S (ORAL)T/S (ORAL)

34www.scabb.org.................................................................................................................


Abstract #10

ABSTRACT TITLE:Initiatives to Reduce Reaction Rates in Yo u n gBlood Donors

ABSTRACT AUTHORS: Paula Gore, MT(ASCP)SBB; Barbara Bryant,MD MT(ASCP)SBB

B A C K G R O U N D : Managing adverse events with youthful donors isa complex issue. Newly enacted state law lowering legal dona-tion age to 16 years old with parental consent coincided withour blood center’s change to 500 ml collection bags. Initiativesto prevent increased reaction rates in young donors at highschool blood drives were implemented and evaluated.

STUDY DESIGN: Education of young donors to pre p a re them forthe process of donation and reduce anxiety was provided via ab ro c h u re. The bro c h u re described the donor questions, mini-physical process, and needles. An emphasis was placed on thedonors being well-hydrated and eating prior to donation.Applied muscle tension methods were explained, and the stu-dents were encouraged to perf o rm these techniques duringdonation. Parents were provided with a bro c h u re and a com-p rehensive parental consent form. Nursing and collection staff sw e re educated to recognize and treat adverse reactions aswell as preventative measures. Staff was allowed to deferdonors who had not eaten within 4 hours and mandate eachdonor drinks an 8 ounce bottle of water prior to donation. Theb a c k g round for the implementation of each strategy wass h a red with staff to reduce anxiety with the flood of new ‘imma-t u re’ donors. The blood center medical director chose toi n c rease the re q u i red weight of all first time donors, in the 16 to23 year old age group, to 120 pounds. The volume collectedwas reduced to 485 ml for all donors. Sandwiches and waterw e re provided for the students, prior to donation, along with thetraditional juice and cookie offering after donation.

R E S U L T S : During the 3-month strategy implementation period,1567 donations were made at high schools. Eighteen percent ofthe blood donors (n= 285) were 16 years old, 33.3% (n=522) were17 years old, 42.4% (n = 665) were 18 years old, and 6.1% (n = 94)w e re older than 18. The majority were first time donors (79%) andfemale (60%). Thirty percent of the donors weighed between120 and 130 pounds. An adverse reaction rate of 2% was re p o r t-ed equally in the 16, 17, and 18 years old donor categories. Theg reater than 18 year old group had a 4% reaction rate to dona-tion. Just over half of the donor reactions were mild, with 24%moderate reactions and 24% severe reactions.

C O N C L U S I O N : With adequate preparation of both staff anddonors, there was no diff e rence in reaction rates between 16year olds and their older classmates. Interestingly, adults (olderthan 18 years of age) experienced an adverse donor re a c t i o nrate two times higher than the 16, 17, and 18 year old donors.Blood center strategies to promote positive blood donationexperiences for these youthful donors resulted in less donor re a c-tions than their older counterparts and may hopefully encour-age future repeat blood donations.

Abstract #11

ABSTRACT TITLE: Transfusion of Group O Red Blood Cells to Non-G roup O Recipients: Analysis and Assessment of Practice

ABSTRACT AUTHORS: Barbara Watson, SBB(ASCP); Barbara Bryant

B A C K G R O U N D : G roup O red blood cells (RBCs) are often trans-fused to non-group O re c i p i e n t s . These “out of group” transfu-sions are done for various reasons: re q u i rements for antigen neg-ative blood; special attributes such as CMV negative, hemoglo-bin S negative, or irradiation; short shelf life; e m e rgent situations prior to patient ABO/Rh determ i n a t i o n ;recipient ABO discre p a n c i e s . Transfusing non-group O patientswith group O RBCs creates no harm for the recipient, howeverthe transfusion of multiple units of group O RBCs can cause ABOtyping difficulties with samples collected post-transfusion andpotentially cause group O blood shortages unnecessarily. Thepurpose of the study was to determine the number and justifica-tion for group O RBC transfusions to non-group O re c i p i e n t s .

M E T H O D S : This study was conducted at a greater than 500 bedtertiary care facility with a large solid organ transplant pro g r a mtransfusing an average of 1100 RBC units per month. All transfu-sions of group O blood to non-group O recipients were includedin this re t rospective 6 month study.

R E S U L T S : During the study period, 2% of the total RBC units trans-fused were group O to non-group O re c i p i e n t s . Forty four per-cent (44%) was due to the re q u i rement of antigen negative RBCunits for patients that had developed allo- or autoantibodies.The transfusion of group O RBCs to non-group O recipients withalloantibodies included group O Rh negative units selected and screened for C antigen and gro u pO Rh positive units selected and tested for c antigen. Short shelflife accounted for 29% of the “out of group” transfusions.Selection of units with special attributes constituted 14% of theset r a n s f u s i o n s . Nine percent (9%) of the group O RBC units transfused to non-group O recipients was due to emer-gent situations requiring the release of blood for patients with noc u r rent ABO/Rh type or cro s s m a t c h . The remaining 4% was dueto recipient ABO typing discrepancies and the use of group ORBCs for patients that were group A- s u b g ro u p .

C O N C L U S I O N : This study demonstrated there were not a signifi-cant percentage of group O RBC transfusions to non-group Orecipients for non-clinical re a s o n s . Short shelf life, special attrib-utes, emergent transfusions without current patient blood type,and ABO typing discrepancies were valid justifications for theuse of non-ABO specific transfusions. A c c o rding to the 2009National Blood Collection and Utilization Survey report, only 8.4%of outdated RBC units in 2008 were group O (5.4% O positiveand 3.0% O negative). S c reening of ABO-identical units for anti-gen negative re q u i rements would reduce the largest cause ofg roup O transfusions to non-group O recipients reported in thisstudy and potentially result in better utilization and less outdatingof ABO-identical RBC units.

T/SDRC

35 .................................................................................................................www.scabb.org


Abstract #12

ABSTRACT TITLE: Blood Inventory Management: A Look at How toC o n t rol the Antigen Negative and Rare Unit Inventory

ABSTRACT AUTHORS: Juanita F. Montgomery MLS(ASCP)

B A C K G R O U N D : Inventory management is a daily process utilizedby blood centers and hospitals to manage their inventory. SouthTexas Blood and Tissue Center in conjunction with QualtexLaboratories has developed a computer program called CrystalReports, which track antigen negative units that are issued tohospitals in the surrounding areas. The system however does nottracks trends or the most popular antigen negative unit combi-nation. There is a need to devise an effective system to manageantigen negative and rare unit inventory. This project is designedto analyze data from the program in the following ways: Tr a c kthe trends of antigen negative units, the most popular combina-tion of antigens at specific times of the year, where re c r u i t m e n tshould take place, and most importantly what antigen negativeunits should be kept on the shelf at all times and what antigennegative units should be tagged as rare and added to thef rozen inventory.

MATERIAL AND METHODS: The data was put into 6 diff e rent excels p readsheets according to the number of negative antigens(single, double, triple, quadruple, 5 and 6 or more). Then, eachof the 6 spreadsheets was analyzed further by month and num-ber of antigens. Monthly calculations include each set of anti-gen negative units summed in each category and the sums areonce again added to give the total number of units issued in themonth. Antigen calculations include the total number of antigennegative units from each month and each set of antigen com-bination summed and then summed once again to give thetotal number of antigen negative units issued in the given timespan. The analysis of the data identified the number of unitsissued in each month, the most frequent single antigen negativeunit and the most frequent combination of antigen negativeunits issued.

O B S E R V A T I O N S : Of the antigen negative units the most fre q u e n tsingle antigen issued was Jka negative units followed by Fya, K,M, E. T h e re was 46 diff e rent antigen combinations for doubleunits, 47 for triple, and 48 quadruple antigen negative units. Thatnumber dropped significantly in the 5 antigen negative units to33 combinations and 17 combinations in the 6 or more antigennegative units. Data was analyzed to show the most popularantigen negative combinations in each category.

C O N C L U S I O N : Blood centers should have an effective means ofmanaging the antigen negative and rare unit inventory.Identifying a root antigen in multiple antigen negative combina-tions, will make it easier to choose the units that should beadded to the rare or frozen unit stock and screening curre n tdonors more effectively. The data provided from the CrystalReports Program is valuable but the software needs to beupdated in a manner capable of tracking trends and the num-ber of combinations of antigen negative units.

Abstract #13

ABSTRACT TITLE: Laboratory Workflow Efficiency Impro v e m e n t sAfter Implementation of a Fully Automated ImmunoassayA n a l y z e r

ABSTRACT AUTHORS: I rma Vi l l a real, MT BB (ASCP); D. Coles; S Jones; L. Myers; J. Beck; B. Marc h l e w i c z

S U M M A R Y : The ABBOTT PRISM instrument system, a fully automat-ed immunoassay analyzer, was implemented in our laboratoryon Jan. 3, 2007, with PRISM HBcore and PRISM HBsAg assays.Over the next 4 years an additional 4 assays have been addedto complete the blood and plasma screening menus, and thep revious semi-automated analyzers and assays were re t i re d .Significant increases in process efficiencies, assay perf o rm a n c ei m p rovements, and increased testing capacity/capabilitiesw e re reported for the new system.Study Objective: This study evaluated the overall laboratory per-f o rmance, efficiency, and capacity improvements obtained fol-lowing the conversion to the PRISM system. The parameters ana-lyzed included the total number of donations tested, the initial(IR) and repeat reactive (RR) rates for each assay marker, thep e rcentage of failed runs, total number of pieces of instrumen-tation and space re q u i red for instruments, the number of FTEsre q u i red to operate the serology lab, and the donations testedper FTE/year.

R E S U L T S : The results were quite striking. While the volume ofdonor testing increased by more than 184% between 2006 and2011, the whole blood donor IR and RR decreased by 55% and47% respectively and the plasma client IR and RR decreased by66% and 42% respectively. There was also a decrease in overallf requency of failed runs from 2.58%-1.28% and a specificd e c rease in failed runs due to technologist error from 0.85%-0.14% which is a 5 fold decrease. The total pieces of instrumen-tation decreased from 80 Commander Instruments to 10 PRISMinstruments, while accommodating almost a 3 fold increase intesting volume. The standardization of equipment resulted in asignificant decrease of instrument maintenance and traininge fforts of staff and reduction in the square footage needs of thelab by 844 square feet, a 44% decrease. Finally, the number ofFTEs responsible for viral marker testing decreased from a peakof 48 in 2007, with annual donations tested per FTE of 72,825 to as t a ff of 19 in 2011, while increasing the annual donations testedper FTE to 460,983, a 485% increase per FTE.

C O N C L U S I O N : The implementation of the PRISM system allowedfor an increase in testing volume capacity, an overall impro v e-ment in laboratory efficiency, allowing almost a 3 fold incre a s ein testing volume in 5 years. There was a significant reduction inreactive rates, equaling to greater than a 50% reduction in lostblood products while retaining over 13,500 donors annually dueto improved assay perf o rmance. Laboratory space re q u i red fortesting instrumentation decreased by 44%.

DRC T/S

36www.scabb.org.................................................................................................................

Abstract #14


T/S

ABSTRACT TITLE: S t a n d a rdizing Whole Blood LaboratoryP roduction with Six Sigma and LEAN Manufacturing

ABSTRACT AUTHOR: Stephen Bassett, MS ME CSSBB (ASQ)

BACKGROUND: Separating whole blood into red blood cells andplasma involves the same process, but work staff perf o rm it dif-f e re n t l y . A measurement system does not exist to assess howlong it takes to process whole blood.

M E T H O D S : We utilized Six Sigma and LEAN Manufacturing tools tos t a n d a rdize the process of separating whole blood into re dblood cells and plasma. Six Sigma is a phased-analysis pro c e s sknown as DMAIC: Define, Measure, Analyze, Improve, andC o n t rol. LEAN manufacturing is a systematic approach forreducing production waste.

OBSERVATIONS: We compared total process time at each loca-tion, as well as the time of each sub process by location.A N O VA revealed a statistically significant diff e rence betweenlocations overall (p<0.00001). The mean total process time var-ied from one and a half, up to several hours. The standarddeviation for total process time varied from about a half hour, upto several hours. A N O VA also revealed that each sub pro c e s sd i ff e red by location significantly (p<0.00001). The mean foreach sub process time varied between locations, usually on theo rder of minutes, but sometimes on the order of hours.

CONCLUSION: We assembled a team of staff from each loca-tion and trained them on LEAN Manufacturing. We were ableto reduce process time by improving the work area and balanc-ing the production flow. We also implemented the same stan-d a rdized work at each location.

37 .................................................................................................................www.scabb.org

FREE!Oral

AbstractsSCABBinar

To be held on

TUESDAYJuly 23, 2013

Distinguished Past Presidents

1958 Louis J. Manhoff, Jr., M.D. Texas1959 John B. Alsever, M.D. (deceased) Arizona1960 Kenneth M. Heard, M.D. (deceased) Mississippi1961 Albert L. McQuown, M.D. Louisiana1962 E. Richard Halden, M.D. (deceased) Texas1963 David E. Soules, Ph.D. Texas1964 L. Ruth Guy, Ph.D. (deceased) Texas1965 J. N. Owens, Jr., M.D. (deceased) Oklahoma1966 Charles F. Pelphrey, M.D. Texas1967 Leslie Ray Bryant, M.D. Louisiana1968 Florence Henderson Texas1969 Douglas W. Terry, M.D. Texas1970 James R. Wheeler, M.D. Texas1971 A. Matthew Gottlieb, Ph.D. Arizona1972 George L. Leonard, M.D. Mississippi1973 John N. Kemp, CAE (deceased) Texas1974 David S. deJongh, M.D. Florida1975 John D. Milam, M.D. Texas1976 Norma M. Bender, MT(ASCP)SBB Louisiana1977 Norwood O. Hill, M.D. Texas1978 Robert A. Fry (deceased) Texas1979 Bill T. Teague, MT(ASCP)SBB Texas1980 Ethel Patten, M.D. Texas1981 Lee Davis Groom, MBA, MT(ASCP)SBB Ohio1982 Margie Peschel, M.D. Texas1983 William Bristow, MT(ASCP) Texas1984 Page Sanchez Meyer, MHS, MT(ASCP)SBB South Carolina

1985 Bobby Grigsby, CPA Texas1986 Toby Simon, M.D. New Mexico1987 Francis Morrison, M.D. (deceased) Mississippi1988 Ronnie Garner, M.D. New Mexico1989 Shannon Cooper, M.D. Louisiana1990 Joe Ridley Texas1991 Byrdie McSwain, BS, MT(ASCP)SBB Arkansas1992 Julie A. Beck, MBA, MT(ASCP)SBB, DLM Texas1993 Trudell S. Green, BA, BS, MT(ASCP)SBB Pennsylvania1994 Kathie Carlson, MT(ASCP)SBB Texas1995 John T. Guthrie, BS Arizona1996 Kathy Houston, MT(ASCP)SBB Colorado1997 Bill Grimes Texas1998 Jennifer Rhamy Indiana1999 Bobby Rodwig, M.D. Louisiana2000 Barbara Laird-Fryer, MT(ASCP)SBB Texas2001 Jo McKelvey, MT(ASCP)SBB Texas2002 Linda Bossard, MT(ASCP)SBB Arizona2003 Chris Coffin, MT(ASCP)SBB Louisiana2004 James T. Rutledge, PhD Texas2005 Paula Kelley, BS, MT(ASCP)SBB Texas2006 Elizabeth Waltman New Mexico2007 James W. Teague, BS, SBB(ASCP) Texas2008 LeaAnn Teague, MBS, MT(ASCP)SBB Louisiana2009 Dennis Harpool, SBB(ASCP) Arizona2010 Nancy Haubert, MBA, MT(ASCP)SBB Texas2011 Jose Garcia Texas

FT. WORTH, TEXASWELCOMES SOUTH CENTRAL

ASSOCIATION OF BLOOD BANKSMarch 30 – April 2, 2014Historic Hilton Ft. Worth

Save the Dateand Spread the Word!

38www.scabb.org.................................................................................................................

PRESIDENT'S LEVEL

ATTENDEE LANYARDS

SPONSOR LEVEL

Thank you to this year’s Annual Meeting Sponsors

WELCOME RECEPTION & EXHIBIT HALL OPENING

ATTENDEE BAG

MEMBERSHIP MIXER

Attendee & Meeting Support Sponsors

COFFEE & BEVERAGE BREAK SPONSOR

SUPPORTER LEVEL

FRIEND LEVEL

OPENING PLENARY SPEAKER

39 .................................................................................................................www.scabb.org

2013 EXHIBIT SHOW DIRECTORY

Company Name Booth #Q u a l Tex Laboratories 1Hemasoft America 2Quotient Biodiagnostics 3Sigma Blood Systems 4Helmer Scientific 5D i g i - Trax Corporation 6LIFECODES, now a part of Immucor 7G e n e s i s B P S 8EmCo Consulting, Inc. 9I m m u c o r, Inc. 10 & 20Andover Healthcare Inc. 1 1Interstate All Battery 1 2Separation Technology, Inc. (STI) 1 3C reative Testing Solutions 1 4Beckman Coulter, Inc. 1 5H a e m o n e t i c s 1 6HemoCue, Inc. 1 7Novartis Diagnostics 1 8Rees Scientific 1 9

Company Name Booth #Roche Diagnostics Corporation 2 1Carter BloodCare 2 2H e a l t h c a re-ID 2 3Terumo BCT 2 4Best Theratronics, Ltd. 2 5Hettich Instruments 2 6IMA (Independent Medical Associates) 2 7William Laboratories, Inc. 2 8M a c o P h a rma USA 2 9Fenwal, a Fresenius Kabi Company 30 & 31L i f e S h a re Blood Centers 3 2M e d i w a re Information Systems, Inc. 33 & 34B i o - R a d 35 & 36Mak-System Corp. 3 7Ashland, Inc 3 8Label Arts 3 9Act Fast Delivery, Inc. 4 0S n a c K i t 4 1National Bus Sales & Leasing 4 2(Specialty Ve h i c l e s )

40www.scabb.org.................................................................................................................


Act Fast Delivery, Inc. 4 02 1 0 - 3 6 4 - 4 0 9 919365 FM 2252 #4Garden Ridge, TX 78266www.actfastdelivery.com

Act Fast Delivery is a total logistics man-agement company providing intrastateand interstate ground and air fre i g h ttransportation services across the UnitedS t a t e s .

Andover Healthcare Inc. 1 18 0 0 - 4 3 2 - 6 6 8 69 Fanaras DriveSalisbury, MA 1952www.andoverhealthcare.comAndover Healthcare, Inc. is a leadingm a n u f a c t u rer of bandages and tapessupplying high quality products made inthe USA. Andover is committed to newand innovative technology and distrib-utes its patented products around thew o r l d .

Ashland, Inc. 3 89 7 3 - 6 2 8 - 3 3 8 31361 Alps RoadWayne, NJ 7470www.radsure.comAshland's two-part quality system assure scompliance with regulations on bloodirradiation. (1) RAD-SURE® Indicators, withISBT 128 bar coded lot numbers, attach tounits of blood and provide positive, visualverification of irradiation. (2) DOSE-MAP®validates and maps the perf o rmance ofblood irradiators. RAD-SURE® UVA indica-tors are also available.

Beckman Coulter, Inc. 1 58 0 0 - 5 2 6 - 3 8 2 1250 S. Kraemer Blvd.Brea, CA 92822www.beckman.com

Beckman Coulter is the worldwide leaderin donor blood typing systems. PK instru-ments have tested over 90% of the NorthAmerican blood supply. The PK7300o ffers the latest technology backed bytrusted reliability and pro d u c t i v i t y .

Best Theratronics, Ltd. 2 56 1 3 - 5 9 1 - 2 1 0 0413 March RoadOttawa, ON K2KOE4www.theratronics.ca

Best® Theratronics Limited, located inOttawa, Canada, is a privately ownedand operated company that manufac-t u res and sells radiation therapy medicalequipment worldwide.

B i o - R a d 35 & 365 1 0 - 7 2 4 - 7 0 0 04000 Alfred Nobel Dr.Hercules, CA 94547www.bio-rad.com/diagnostics

Bio-Rad Laboratories, a leading clinicaldiagnostics company, is focused onmeeting the needs of laboratories, includ-ing Blood Banks and Blood DonorCenters. Bio-Rad delivers this by off e r i n ga broad portfolio of blood bank pro d u c t s .

Carter BloodCare 2 28 1 7 - 4 1 2 - 5 0 0 02205 Highway 121Bedford, TX 76021www.carterbloodcare.orgCarter BloodCare is a not for pro f i t501(c)(3) full service blood center pro v i d-ing a comprehensive portfolio of labora-tory, cellular therapy and clinical aphere-sis services to healthcare providers, hospi-tals and other blood centers.

Creative Testing Solutions 1 48 1 7 - 4 1 2 - 6 1 2 42205 Highway 121Bedford, TX 76021www.mycts.orgC reative Testing Solutions is the standardfor proven and reliable blood and tissuetesting. Experienced professionals, state-of-the-art equipment, and unwaveringquality inspire confidence in our diverseclient base. We are your solution for all ofyour testing needs. Visit us at MyCTS.org .

Digi-Trax Corporation 68 4 7 - 6 1 3 - 2 1 1 6650 Heathrow DrLincolnshire, IL 60069www.Digi-Trax.com

D i g i - Trax provides barcode label systems,validation and technical support to bloodbanks, transfusion centers and cellulartherapy (CT) departments. Find out aboutH e m a Trax-UNITY™ our new software, andH e m a Tr a x - C T; HemaTrax-BC(OR dept.);and RepliTrax™ (label re p l i c a t i o n ) .

EmCo Consulting, Inc. 98 5 0 - 4 5 7 - 0 3 3 0604 New Warrington Rd.Pensacola, FL 32507www.emcoco.com

Full service biomedical, solid, re c y c l i n g ,g rease, used cooking oil, shre d d i n gwaste, and cost reduction consulting firm .Better ideas for improvement at no risk forour clients.

Fenwal, a Fresenius Kabi C o m p a n y 30 & 318 4 7 - 5 5 0 - 2 3 0 03 Corporate DriveLake Zurich, IL 60047www.fenwalinc.com

Fenwal, a Fresenius-Kabi Company, is aglobal blood technology company dedi-cated to supporting transfusion medicineand cell therapies. We help ensure theavailablility, safety and effectiveness oft reatments that depend on blood - medi-cine's most vital natural re s o u rc e .

G e n e s i s B P S 82 0 1 - 7 0 8 - 1 4 0 065 Commerce WayHackensack, NJ 7601www.genesisbps.com

GenesisBPS™ is a manufacturer and dis-tributor of a wide array of specialty bloodp rocessing devices. Whether it'sCollection, Processing, Storage &P reparation, or Cell Processing devices,we have it all. Www.genesisBPS.com orcall 866-71-BLOOD

H a e m o n e t i c s 1 67 8 1 - 8 4 8 - 7 1 0 0400 Wood RoadBraintree, MA 2184www.haemonetics.com

Haemonetics is a global healthcare com-pany dedicated to providing innovativeblood management solutions. Our pro d-ucts and consulting services deliver a suiteof business solutions to help blood collec-tors, hospitals and patients. To learn moreabout Haemonetics, visit our website ath t t p : / / w w w . h a e m o n e t i c s . c o m .

41 .................................................................................................................www.scabb.org


H e a l t h c a r e - I D 2 38 4 7 - 4 6 5 - 9 9 3 51635 Barclay BlvdBuffalo Grove, IL 60089www.healthcare-id.com

H e a l t h c a re -ID's Donor-ID Web automatesdocumentation at fixed and mobile col-lection sites and interfaces to mostBCDMS/BECS. Modules: Registration,Health History, CASI, Internet CASI,Physical Exam, Daily QC, Phlebotomy,Shipping, Survey, Donor Adverse Reaction(AABB biovigilence).

Helmer Scientific 53 1 7 - 7 7 3 - 9 0 7 314400 Bergen Blvd.Noblesville, IN 46060www.helmerinc.com

Helmer is a manufacturer and worldwidedistributor of high quality laboratoryequipment and refrigerated pro d u c t s .Visit our booth to see our new i.C3 avail-able on all i.Series Refrigerators andF re e z e r s .

Hemasoft America 22 1 4 - 4 5 4 - 7 6 0 23301 Kimble DrivePlano, TX 75025www.hemasoft.com

Hemasoft® An International Companywith solutions for Blood Centers, BloodBanks, Cellular Therapy, Cord Blood, andTissue. Our Web-enabled software suitee-Delphyn® is in over 500 locations in 40countries supporting multiple languagessuch as English, Arabic, Chinese, Fre n c hand more .

HemoCue, Inc. 1 78 0 0 - 8 8 1 - 1 6 1 11133 Valley View StreetCypress, CA 90630www.hemocue.com

The HemoCue family of companies, aQuest Diagnostics susidiary, is a globalleader in point-of-care testing. HemoCueAB (Angelholm, Sweden), introduced in1982 the first accurate, near- p a t i e n themaglobin test. The company alsom a n u f a c t u res point-of-care tests for glu-cose, urine albumin, and total whiteblood cell count. For more information, visit www.hemocue.com.

Hettich Instruments 2 68 6 6 - 3 7 0 - 4 3 8 8136 L Cumming CenterBeverly, MA 1915www.hettweb.com

Hettich is one of the leading clinical andre s e a rch centrifuge manufacturers in theworld. Offering over 100 years of engi-neering, design and manufacturing expe-rience in the clinical, re s e a rch and life sci-ences laboratory. We manufacture acomplete line of centrifugation equip-ment ranging from small tabletop micro-liter centrifuges to mid-sized high capacitybenchtop centrifuges and large floorstanding units for high throughput labora-tories such as blood banks and bloodc e n t e r s .

LIFECODES, now part of Immucor 72 6 2 - 7 5 4 - 1 0 0 020925 Crossroads Circle Suite, 200Waukesha, WI 53186www.gen-probe.com

LIFECODES, a division of Immucor, Inc.,designs, manufactures and markets avariety of in vitro diagnostic antibody andgenotyping products for use in clinicallaboratories. Our products include assaysfor the detection of antibodies to plateletantigens an blood group genotyping.

IMA (Independent Medical Associates) 2 77 2 7 - 5 4 8 - 4 4 6 211733 - 66th St. N. #113Largo, FL 33773www.i-ma.com

IMA is a specialty medical sales and distri-bution organization whose purpose is tosupply state-of-the-art medical pro d u c t sfor the blood banking industry from ourmanufacturing partners, Charter Medicaland Medicore .

Immucor, Inc. 10 & 207 7 0 - 4 4 1 . 2 0 5 13150 Gateway DriveNorcross, GA 30071www.immucor.com

I m m u c o r, Inc. is a global leader in pre -transfusion diagnostics. We develop,m a n u f a c t u re, and support a completeline of manual reagents, unique specialtyp roducts, and a scalable family of fully-automated instruments for the bloodbank laboratory.

Interstate All Battery 1 29 7 2 - 8 0 4 - 9 0 3 912770 Merit DriveDallas, TX 75251www.interstate.com

Interstate All Battery Center has morethan 16,000 power solutions, saving ourblood service partners up to 60% on bat-tery costs with quality standards equal toor exceeding the original equipmentm a n u f a c t u re r.

Label Arts 3 99 0 3 - 4 9 8 - 6 0 4 120159 State Hwy 274Kemp, TX 75143www.labelarts.com

Label Arts is a leader in producing high-quality labels for use by hospitals, labora-tories, clinics, and blood banks worldwide.Our labels range from basic paper labelsto chemical-resistant labels used in theharshest of environments. We specialize inprinting sequentially numbered and bar-coded labels in a variety of fonts includ-ing the ISBT 128 standards. All our labelsa re customizable to meeting the specificneeds of our customers.

LifeShare Blood Centers 3 23 1 8 - 6 7 3 - 1 5 3 68910 Linwood AveShreveport, LA 71106www.lifeshare.org

The staff from Scientific Support Servicesand the Immunohematology Refere n c elab will be here to discuss genotyping(RBC, platelets, RHD/CE), specialized test-ing including MMA, rare donor availabilityand other services off e red by LifeShare .

MacoPharma USA 2 97 7 0 - 2 7 0 - 6 8 6 73675 Crestwood Pkwy, Suite 260Duluth, GA 30096www.unitedpharma.org

M a c o p h a rma USA specializes in qualityBLOOD COLLECTION PROCESSING SYS-TEMS and SERVICES. Our turn k e ya p p roach provides blood centers with allthe key systems components - from the fil-ter to the bag.

42www.scabb.org.................................................................................................................


Mak-System Corp. 3 78 4 7 - 8 0 3 - 4 8 6 32720 River Road - Suite 225Des Plaines, IL 60018www.mak-system.net

MAK-SYSTEM International Group is aleading medical information technologycompany providing a broad portfolio ofi n f o rmation management systems toh e a l t h c a re organizations worldwide.Since its inception in 1984, MAK-SYSTEMhas specialized in designing innovatives o f t w a re solutions that deliver superiorfunctionality to tissue banks, cellular thera-py laboratories, blood banks and bloodtransfusion services.

Mediware Information Systems, Inc. 33 & 34(913) 307-101511711 W. 79th Stre e tLenexa, KS 66214www.mediware.comM e d i w a re® is a leading provider of spe-cialized healthcare solutions with overfour decades of exerience developingand delivering innovative softwaredesigned to ensure the highest level ofsafety and efficiency for the hospital andblood center.

National Bus Sales & Leasing (Specialty Vehicles) 4 2

8 0 0 - 2 8 2 - 7 9 8 1800 Pickens DriveMarietta, GA 30062www.nationalbussales.comNational Bus Sales and Leasing, Inc. is oneof America's premier suppliers of SpecialtyVehicles. From design to delivery ourexperts are with you all the way. OurParts and Service teams keep you on theroad year after year.

Novartis Diagnostics 1 8

5 1 0 - 4 9 9 - 2 7 5 64560 Horton StEmeryville, CA 94608www.novartisdiagnostics.com

Dedicated to preventing transfusion-trans-mitted diseases, Novartis Diagnostics,delivers innovative blood screening solu-tions worldwide. The PROCLEIX® assaysand systems, developed in collaborationwith Gen-Probe, use nucleic acid testing( N AT) technology to detect RNA and

DNA in donated blood and blood pro d-ucts, a method proven to reduce the viraldetection window.

QualTex Laboratories 12 1 0 - 7 3 6 - 8 9 5 26211 IH 10 West @ First Park Ten Blvd.San Antonio, TX 78201www.stbtc.orgQ u a l Tex Laboratories is a full service labo-ratory that screens millions of donor speci-mens for infectious agents each year forblood and tissue banks, plasma centersand biotechnology companies locallyand across the globe.

Quotient Biodiagnostics 3

8 8 8 - 2 8 4 - 1 9 0 1301 S. State Street, Suite S-204Newton, PA 18940www.quotientbiodiagnostics.comQuotient Biodiagnostics has suppliedmajor transfusion diagnostics companiesworldwide for over 30 years. Quotientnow offers its manual ALBAclone® andALBAcyte® reagents, specialty kits andenhancement media to customers in theU . S .

Rees Scientific 1 9

6 0 9 - 5 3 0 - 1 0 5 51007 Whitehead Rd. Ext.Trenton, NJ 8638www.reesscientific.comRees Scientific's Centron Enviro n m e n t a lMonitoring Systems protect your criticalblood supply by providing compliance,validation, centralized alarm notification,automatic reporting, and wireless and / orh a rd w i red sensors. Meets thoughests t a n d a rds for Joint Commission, AABB &F D A .

Roche Diagnostics Corporation 2 1Sponsor Level

3 1 7 - 6 9 1 - 8 7 6 49115 Hague RoadIndianapolis, IN 46250www.roche.comRoche Diagnostics, a leading Healthcarecompany, offers the uniquely compre-hensive cobas Ta q S c reen MPX Test for useon the cobas s 201 system, which detectsH I V-1 Group M, HIV-1 Group O, HIV- 2 ,HCV and HBV in donor samples.

Separation Technology, Inc. (STI) 1 3

4 0 7 - 7 8 8 - 8 7 9 1582 Monroe Road, Suite 1424S a n f o rd, FL 32771www.separationtechnology.comSTI provides two superior hematocritdonor screening systems. UltraCrit™ usesultrasound technology for high accuracyresults and low user subjectivity.H e m a t a S TAT® provides a hematocrit inone minute with a very low cost per test.

Sigma Blood Systems 4

4 0 5 - 2 2 7 - 0 6 0 6800 Research Parkway Suite, 336Oklahoma City, OK 73104www.sigmablood.com

Sigma Blood Systems helps blood centersautomate and manage their operationsand compliance re q u i rements forP roduct QC and Apheresis PlateletManufacturing. Our customized softwaresuite includes QC Manager™, PlateletManager™ and Vi s i o n C e n t r i c ™ .

S n a c K i t 4 1

2 8 1 - 4 6 7 - 1 9 0 93602 El JamesSpring, TX 77388www.donorsnackit.comSnacKit streamlines blood centers cantenoperation by providing pre-kitted re f re s h-ments. SnacKit offers efficiencies such asreducing inventory storage, handling andtouches, eliminating daily canteen stag-ing and simplifying expiration date man-a g e m e n t .

Terumo BCT 2 4P resident's Circle Sponsorship

8 7 7 - 3 3 9 - 4 2 2 810811 W. Collins Av e n u eLakewood, CO 80215www.terumobct.comTerumo BCT, a global leeader in bloodcomponent and cellular technologies, isthe only company with the unique combi-nation of apheresis collections, manualand automated whole blood pro c e s s i n g ,and pathogen reduction coupled withleading technologies in therapeutica p e resis and cell pro c e s s i n g .

43 .................................................................................................................www.scabb.org

2013 Annual Meeting & Exhibit Show Information

ANNUAL MEETING FEES

Full Meeting Registration(Includes Thursday through Sunday and all social events)

Member . . . . . . . . . . . . . . . . . . . . . . $385.00Non-Member . . . . . . . . . . . . . . . . . . $460.00Physician in Training/Student . . . . . $175.00*Flex Pass . . . . . . . . . . . . . . . . . . . . . $385.00

*Flex Pass allows multiple attendees to register at one discounted rate and isonly open to SCABB Institutional Members

Single-Day Registration (Daily registrations include all planned meal functions for that day, with the exception of the President’s Aw a rds Banquet)

Member . . . . . . . . . . . . . . . . . . . . . . $185.00Non-Member . . . . . . . . . . . . . . . . . . $210.00Physician in Training/Student . . . . . $105.00

Guest tickets for President’s Reception and Awards Banquet - $50.00.

Meal Functions Full meeting registration includes all scheduled meal functions. Daily registrations include all coffee breaks and lunch off e red that day. Dailyregistrations do not include the President’s Reception and Aw a rds Banquet,however tickets can be purchased for this very special evening of celebrationfor $50.00

Ground Transportation The Belle of Baton Rouge provides free shuttle service to and from the BatonRouge Airport. Contact the Belle of Baton Rouge to advise them of yourarrival time. Flying in to New Orleans? Tiger Airport Shuttle pro v i d e sshuttle service from the Louis Arm s t rong New Orleans International Airportto the Belle of Baton Rouge hotel. Visit www.tigerairportshuttle.com f o rdetails and pricing.

Conference Attire“Business Casual” is appropriate for all meetings and events unless otherwiseindicated. A sweater or light jacket is recommended because meeting ro o m smay be cool.

Hotel Parking For those attendees driving to Baton Rouge, ample parking is available in theBelle of Baton Rouge parking garage. The rate is $10.00 / day or current pric-

ing based on special promotions. Directions to theBelle of Baton Rouge can be found onwww.scabb.org > 2013 Annual Meeting.

102 France Street Baton Rouge, LA 70802 (225) 242-2600

2013 EXHIBIT SHOW DIRECTORY(continuted from page 42)

William Laboratories, Inc. 2 8

8 0 0 - 7 6 7 - 7 6 4 35 Anngina Dr., Unit BEnfield, CT 6082www.williamlabs.com

William Laboratories manufactures Safe-T-Vue® and Tr a n s - Vue™ nonreversible tem-p e r a t u re indicators. Its newest pro d u c t ,Va l - A - S u re™ cooler validation kit, will be ondisplay in our booth.

The South Central Association of BloodBanks Foundation was established in 1987for the sole purpose of enhancing theeducational goals of South CentralAssociation of Blood Banks. Today, 26 yearsl a t e r, the SCABB Foundation continues tog row and provide financial support to theAssociation in the form of annual meetingscholarships, speaker honorariums andother program supplementation. To makea donation to the Foundation visitwww.scabb.org > About SCABB > SCABBF o u n d a t i o n .

44www.scabb.org.................................................................................................................

Advanced Immunohematology andMolecular Symposium features nation-ally recognized Marion Reid. PhD. CaseStudies, IRL Standards, CPT Coding andm o re! On-site Registration Available atw w w . s c a b b . o r g for details.

THURSDAY, APRIL 18T i m e Tr a c k / R o o m P r e s e n ta t i o n / E ve n t S p e a ke r s

8:00 - 12:45 LSU Golf Course Ed Moore Memorial Golf Classic

12:00 - 5:00 Livingston Registration Open

2:15 - 3:15 Baton Rouge West Industry Workshop presented by Sigma Blood Systems, LLC. • Max Doleh• Patrick Saxton

3:15 - 4:00 Courtyard Membership & Protégé Mixer

3:30 - 4:30 Baton Rouge West Industry Workshop presented by Fenwal, A Fresenius Kabi Company • Kathy Mickles• Mary McCarthy

4:45 - 6:00 ALL - Iberville A & B & C Opening Plenary • Kirk Kitchen, SCABB President• Stanley "Skip" Bertman

6:00 - 8:00 Capital Atrium WELCOME RECEPTION/EXHIBIT HALL OPENING

FRIDAY, APRIL 19T i m e Tr a c k / R o o m P r e s e n ta t i o n / E ve n t S p e a ke r s


7:30 - 8:30 Baton Rouge West Industry Workshop presented by Terumo BCT • Richard J. Benjamin, MD PhD FRCPath

8:45 - 10:00 TS - Iberville A & B "Baby Talk" - Neonatal Transfusion Concerns and Complications • Ghislain Noumsi, MD SBB (ASCP) • Daniel K. Noland, MD

8:45 - 10:00 DRC - Baton Rouge West Generational Management • Kathy Tokerud

8:45 - 10:00 A - Baton Rouge East Statewide Collaborations: ACTS & OneBlood • Bobby Grigsby, CPA MBA • George "Bud" Scholl

10:00 - 10:15 BREAK

10:15 - 11:45 TS - Iberville A & B Are You Smarter Than a MedTech Student? • Joann Moulds, PhD MT (ASCP) SBB• Janet Vincent, SBB (ASCP

10:15 - 11:45 DRC - Baton Rouge West QA Bootcamp • Brandi Wright

10:15 - 11:45 A - Baton Rouge East LEAN+ • Galen Kline, CLS SBB • Patrick Maul

11:45 - 1:00 LUNCH BREAK IN EXHIBIT HALL

1:00 - 2:30 TS - Iberville A & B Radical Blood Banking • Major Christopher A VanFosson • Eugenia Bryan, MD

1:00 - 2:30 DRC - Baton Rouge West Donor Motivation • Todd Abner, BA

1:00 - 2:30 A - Baton Rouge East Adult Learning • Christi Brooks, MA MT (ASCP) CQA (ASQ)

2:30 - 2:45 BREAK

2:45 - 4:15 ALL - Iberville A & B & C Secondary Bacterial Screening of Platelet Components • Richard Benjamin, MD PhD FRDPath • Louis Katz, MD

• Patricia Williams, BS MT (ASCP) SBB

4:15 - 6:00 Capital Atrium Exhibit Hall Open

4:30 - 5:30 Baton Rouge East MD Roundtable Discussion

6:30 - 10:00 Old Governor's Mansion PRESIDENT'S RECEPTION & AWARDS BANQUET

SATURDAY, APRIL 20T i m e Tr a c k / R o o m P r e s e n ta t i o n / E ve n t S p e a ke r s

6:30 - 7:30 Lobby Fun Run


7:30 – 8:30 Baton Rouge West Industry Workshop presented by Williams Laboratories, Inc. • Ed Sharpless

(continued on next page)

SCHEDULE AT A GLANCE

45 .................................................................................................................www.scabb.org

SCHEDULE AT A GLANCE

SATURDAY, APRIL 20T i m e Tr a c k / R o o m P r e s e n ta t i o n / E ve n t S p e a ke r s

8:45 – 10:00 ALL - Iberville A & B & C Oral Abstracts Presentations • Michael Scabet, MT (ASCP) SBB• Joann Moulds, PhD MT (ASCP) SBB• Barbara Bryant, MD, MT (ASCP) SBB

• Elizabeth Hill, Elizabeth Hill, MT (ASCP) SBB• Yasmine King, MT (ASCP) SBB MPH

10:00 - 10:15 BREAK

10:15 - 11:45 TS - Iberville A & B "Cool Cases" • Alice Chen, MD PhD• Teresa Bruce, MT (ASCP)

10:15 - 11:45 DRC - Baton Rouge West Collections/Recruitment Roundtable Discussion

10:15 - 11:45 Baton Rouge East Manufacturing Based Upon Historical Ordering Practices • Patrick Saxton

11:45 - 2:15 LUNCH BREAK IN EXHIBIT HALL

2:15 - 3:45 TS - Iberville A & B Talk to Me: The Reference Lab/Transfusion Service • Cindy Steinmetz, MT (ASCP)Dialogue - What Everyone Means • Lauro Guerro Jr, MT (ASCP)

• Mary Lieb, MT (ASCP) SBB

2:15 – 3:45 DRC - Baton Rouge West "A Happy Marriage: Uniting Recruitment and Donor Services" • Carla Peterson, MPA• Chad Douglas, MHA ACHE

2:15 - 3:45 A - Baton Rouge East What About the O Negs? • James Barbeau, MD JD FCAP)• Jeremy Himel

• Frances R. Rodwig Jr, MD MPH

3:45 - 4:00 BREAK

4:00 - 5:00 ALL - Iberville A & B & C Ask the Experts

5:00 - 5:45 BREAK

5:45 - 6:15 Ascension SCABB ANNUAL BUSINESS MEETING

SUNDAY, APRIL 21T i m e Tr a c k / R o o m P r e s e n ta t i o n / E ve n t S p e a ke r s


8:30 - 10:00 ALL - Iberville A & B & C Award Lectures • Susan Johnson, MSTM MT (ASCP) SBB• Mary Beth Bassett, BS MT (ASCP)

10:00 - 10:15 BREAK

10:15 - 11:30 ALL - Iberville A & B & C Karen Williams Memorial Lecture • Mark E. Brecher, MD

11:30 Annual Meeting Adjourn

11:30 - 12:30 Baton Rouge West AIMS Industry Workshop presented by Novartis Vaccines • Núria Nogués Galvez, PhD& Diagnostics, Inc. • Jerry A Holmberg, PhD

12:30 - 5:00 Iberville A & B & C Advanced Immunohematology & Molecular Symposium (AIMS) • Mark Yazer, MDSeparate Registration Required • Christine Lomas-Francis, MSc FIBMS

• Katrina Billingsley, MT (ASCP) SBB• Virginia Reyes, Med MT (ASCP) SBB

• Lauro Guerro, BS MT (ASCP)• Sandy Wortman, MT (ASCP) SBB• Cindy Steinmetz, MT (ASCP)

MONDAY, APRIL 22T i m e Tr a c k / R o o m P r e s e n ta t i o n / E ve n t S p e a ke r s

8:00 - 4:15 Iberville A & B & C Advanced Immunohematology & Molecular Symposium (AIMS) • Sue Johnson, MSTM MT (ASCP) SBBSeparate Registration Required • Joann Moulds, PhD MT (ASCP) SBB

• Marion E. Reid, PhD DSc (Hon.)• Nicholas Seay

• Suzanne Davisson, BS SBB (ASCP) CM• Margaret Keller, PhD

• Cindy Flickinger, MT (ASCP) SBB

4:15 AIMS Adjourn

46www.scabb.org.................................................................................................................

president’s message - scabb

Documents